GWAS
Diversity Monitor
Additional Information
Metric
By
Participants
Stage
Discovery
GWAS
Diversity Monitor
Additional Information
Privacy Policy
NHGRI-EBI Catalog
GitHub
How to cite this
Global Initiative
Q&As
Loader
Total GWAS participants diversity
Version 1.0.0. Last check for data: 2021-06-14 06:07:01 .
88.64%
European
7.11%
Asian
0.33%
African
0.85%
African American or Afro-Caribbean
0.78%
Hispanic or Latin American
2.28%
Other/Mixed
Ancestry over time by parent term
Discovery
Stage
All parent terms
Other measurement
Hematological measurement
Lipid or lipoprotein measurement
Inflammatory measurement
Cardiovascular measurement
Liver enzyme measurement
Cancer
Neurological disorder
Other disease
Immune system disorder
Digestive system disorder
Other trait
Body measurement
Biological process
Response to drug
Metabolic disorder
Cardiovascular disease
OR
Femoral neck bone geometry
Lumbar spine bone mineral density
Blood protein levels
Renal cell carcinoma
Heart rate
Heart rate variability traits (RMSSD)
Heart rate variability traits (SDNN)
Cerebral blood flow
Depressive symptoms (MTAG)
Subjective well-being (MTAG)
Neuroticism (MTAG)
Neuroticism
Depressive symptoms
Subjective well-being
Telomere length
Sjögren's syndrome
Graves' disease
Hashimoto thyroiditis
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)
Fear of severe pain
Fear of minor pain
Fear of medical pain (dental)
Fear of pain
Pediatric non-alcoholic fatty liver disease activity score
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
Pediatric nonalcoholic steatohepatitis
BMI x dairy intake interaction (1df interaction test)
Atopy
IgG sialylation phenotypes (multivariate analysis)
IgG disialylation phenotypes (multivariate analysis)
IgG monosialylation phenotypes (multivariate analysis)
IgG fucosylation phenotypes (multivariate analysis)
IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis)
IgG galactosylation phenotypes (multivariate analysis)
IgG monogalactosylation phenotypes (multivariate analysis)
IgG digalactosylation phenotypes (multivariate analysis)
IgG N-glycosylation phenotypes (multivariate analysis)
Insomnia complaints
Sleep duration
Insomnia complaints (sex interaction)
Insomnia complaints (continuous)
Insomnia complaints (dichotomous)
Chronotype
Ease of getting up in the morning
Daytime nap
Snoring
Daytime sleepiness
Testicular germ cell tumor
Borderline personality disorder
Tuberculosis
Endometriosis
Cannabis dependence symptom count
Cannabis dependence
Left ventricular function change in anthracycline treatment
Intelligence
Eosinophil percentage of white cells
Mean corpuscular volume
Platelet count
Hematocrit
Mean corpuscular hemoglobin concentration
Eosinophil counts
Plateletcrit
Granulocyte percentage of myeloid white cells
Monocyte percentage of white cells
White blood cell count
High light scatter reticulocyte count
Sum neutrophil eosinophil counts
Granulocyte count
High light scatter reticulocyte percentage of red cells
Hemoglobin concentration
Platelet distribution width
Eosinophil percentage of granulocytes
White blood cell count (basophil)
Reticulocyte fraction of red cells
Sum basophil neutrophil counts
Red cell distribution width
Reticulocyte count
Neutrophil percentage of granulocytes
Sum eosinophil basophil counts
Monocyte count
Peak insulin response
Acute insulin response
Insulin secretion rate
Insulin disposition index
Insulin disposition index (BMI adjusted)
Peak insulin response (BMI and insulin secretion adjusted)
Peak insulin response (insulin secretion adjusted)
Acute insulin response (insulin secretion and BMI adjusted)
Acute insulin response (insulin secretion adjusted)
insulin secretion rate (BMI adjusted)
Glaucoma (primary open-angle)
Gout
Gout vs. Hyperuricemia
Hyperuricemia
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"
Heart rate response to beta blockers (atenolol monotherapy)
Heart rate response to beta blockers (atenolol add-on therapy)
Heart rate response to beta blockers
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)
Heart rate increase in response to exercise
Heart rate response to recovery post exercise (30 sec)
Heart rate response to recovery post exercise (40 sec)
Heart rate response to recovery post exercise (50 sec)
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (20 sec)
Temporomandibular joint disorder
Insulin levels in response to oral glucose tolerance test (fasting)
Glucagon levels in response to oral glucose tolerance test (fasting)
GIP levels in response to oral glucose tolerance test (fasting)
GLP-1 levels in response to oral glucose tolerance test (fasting)
Insulin levels in response to oral glucose tolerance test (30 minutes)
Insulin levels in response to oral glucose tolerance test (120 minutes)
GLP-1 levels in response to oral glucose tolerance test (120 minutes)
GIP levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels in response to oral glucose tolerance test (120 minutes)
Prostate cancer
Small vessel stroke
Visceral adipose tissue/subcutaneous adipose tissue ratio
Subcutaneous adipose tissue adjusted for BMI
Visceral adipose tissue adjusted for BMI
Total adipose tissue adjusted for BMI
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
Subcutaneous adipose tissue
Visceral adipose tissue
Total adipose tissue
Restricted and repetitive behaviours in autism spectrum disorder
Atrial fibrillation (SNPxSNP interaction)
Anorexia nervosa
Dehydroepiandrosterone sulphate levels
Glycated hemoglobin levels
Alanine transaminase levels
Serum albumin level
Serum alkaline phosphatase levels
Fibrinogen levels
Aspartate aminotransferase levels
"Cholesterol, total"
Creatinine levels
Gamma glutamyl transferase levels
HDL cholesterol
Hemoglobin levels
C-reactive protein levels
Insulin-like growth factor 1 levels
Ferritin levels
Testosterone levels
Triglyceride levels
Urea levels
LDL cholesterol
Glomerular filtration rate
Chickenpox
Shingles
Cold sores
Mumps
Plantar warts
Bacterial meningitis
Yeast infection
Myringotomy
Measles
Hepatitis A
Rheumatic fever
Number of common colds
Chronic sinus infection
Urinary tract infection frequency
Tonsillectomy
Childhood ear infection
Rubella
Mononucleosis
Hepatitis B
Strep throat
Scarlet fever
Pneumonia
Psoriasis
Rheumatic heart disease
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
Body mass index
Waist circumference adjusted for body mass index
Waist-to-hip ratio adjusted for body mass index
Body mass index (physical activity interaction)
Waist circumference adjusted for BMI (physical activity interaction)
Waist-to-hip ratio adjusted for BMI (physical activity interaction)
Body mass index (joint analysis main effects and physical activity interaction)
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
Body mass index in physically active individuals
Body mass index in physically inactive individuals
Waist circumference adjusted for BMI in active individuals
Waist circumference adjusted for BMI in inactive individuals
Waist-to-hip ratio adjusted for BMI in active individuals
Waist-to-hip ratio adjusted for BMI in inactive individuals
Preterm birth (maternal effect)
Gestational age at birth (maternal effect)
"DDT metabolite (p,p'-DDE levels)"
Parental longevity (at least one long-lived parent)
Itch intensity from mosquito bite adjusted by bite size
Mosquito bite size
Perceived unattractiveness to mosquitoes
Itch intensity from mosquito bite
Diastolic blood pressure
Mean arterial pressure
Systolic blood pressure
Pulse pressure
Hypertension
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)
Rheumatoid arthritis
Food allergy (parent-of-origin effect)
Peanut allergy (parent-of-origin effect)
Milk allergy (parent-of-origin effect)
Egg allergy (parent-of-origin effect)
Food allergy (maternal genetic effects)
Peanut allergy (maternal genetic effects)
Milk allergy (maternal genetic effects)
Egg allergy (maternal genetic effects)
Multiple keratinocyte cancers
Fuchs's corneal dystrophy
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease
Major coronary event in placebo-treated cardiovascular disease (time to event)
Diarrhoea in darapladib-treated cardiovascular disease (time to event)
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)
Myocardial infarction in placebo-treated cardiovascular disease (time to event)
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)
Odor events in darapladib-treated cardiovascular disease (time to event)
Major coronary event in darapladib-treated cardiovascular disease (time to event)
Lipoprotein phospholipase A2 activity in cardiovascular disease
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)
Smoking interaction in non-small cell lung cancer (1df test)
Smoking interaction in lung adenocarcinoma (1df test)
Smoking interaction in squamous cell lung cancer (1df test)
Cow's milk allergy
Food allergy
Peanut allergy
Hen's egg allergy
Idiopathic osteonecrosis of the femoral head
Interleukin-12p70 levels
Interleukin-16 levels
Monocyte chemoattractant protein-1 levels
Monocyte chemoattractant protein-3 levels
Macrophage colony stimulating factor levels
Monokine induced by gamma interferon levels
Macrophage inflammatory protein 1a levels
Macrophage inflammatory protein 1b levels
Platelet-derived growth factor BB levels
RANTES levels
Stem cell factor levels
Stem cell growth factor beta levels
Stromal-cell-derived factor 1 alpha levels
Tumor necrosis factor alpha levels
Tumor necrosis factor beta levels
TRAIL levels
Fasting blood insulin
Fasting blood glucose
Fasting blood insulin adjusted for BMI
Height
Very low density lipoprotein cholesterol levels
Waist circumference
Weight
Waist-hip ratio
Hemoglobin
Homeostasis model assessment of insulin resistance
Homeostasis model assessment of insulin resistance adjusted for BMI
Low density lipoprotein cholesterol levels
Mean corpuscular hemoglobin
Red blood cell count
Total cholesterol levels
Opioid dependence
Diffuse cutaneous systemic sclerosis
Systemic sclerosis
Limited cutaneous systemic scleroderma
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Neuritic plaques or neurofibrillary tangles (pleiotropy)
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy
Breast cancer in childhood cancer survivors
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Primary vesicoureteric reflux
Alcohol dependence symptom count
Alcohol consumption (max-drinks)
Response to alcohol consumption (flushing response)
Lung function (maximal voluntary ventilation)
Lung function (forced expiratory volume in 1 second)
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)
Lung function (forced vital capacity)
Lung function (FEV1/FVC)
Attention deficit hyperactivity disorder (sex interaction)
Sex difference in attention deficit hyperactivity disorder
Attention deficit hyperactivity disorder
Colorectal cancer
Alzheimer's disease
Alzheimer's disease (APOE e4 interaction)
Alzheimer's disease in APOE e4+ carriers
Alzheimer's disease in APOE e4- carriers
Femoral neck bone mineral density
Breast cancer
Alzheimer's disease (age of onset)
Urinary magnesium-to-creatinine ratio
Fractional excretion of magnesium
Serum magnesium levels
Pulmonary arterial hypertension
Low-grade serous and serous borderline ovarian cancer
Ovarian cancer in BRCA2 mutation carriers
Epithelial ovarian cancer
Ovarian clear cell cancer
Endometrioid ovarian cancer
Mucinous ovarian carcinoma
Serous invasive ovarian cancer
Serous borderline ovarian cancer
High-grade serous ovarian cancer
Low-grade serous ovarian cancer
Ovarian cancer in BRCA1 mutation carriers
Invasive epithelial ovarian cancer
Rheumatoid arthritis (ACPA-positive)
Response to platinum-based neoadjuvant chemotherapy in cervical cancer
Sperm motility
Bipolar disorder
Polycystic ovary syndrome
Orofacial clefts (cleft lip vs. cleft lip and palate)
PR interval
Coronary artery disease
Theory of mind score in adolescence (Emotional Triangles Task)
ACPA-negative rheumatoid arthritis (smoking interaction)
ACPA-positive rheumatoid arthritis (smoking interaction)
Open-angle glaucoma and optic cup area
Open-angle glaucoma and optic disc area
Open-angle glaucoma and vertical cup-disc ratio
Open-angle glaucoma and intra-ocular pressure
Idiopathic dilated cardiomyopathy
Blood osmolality (transformed sodium)
NHDL cholesterol to HDL cholesterol ratio
LDL cholesterol to HDL cholesterol ratio
Triglyceride to HDL cholesterol ratio
Body mass index x sex interaction
Body mass index x sex x age interaction (4df test)
Body mass index (age>50)
Body mass index (age <50)
Body mass index x age interaction
Body mass index x sex x age interaction
Waist-to-hip ratio adjusted for BMI
Waist-to-hip ratio adjusted for BMI (age <50)
Waist-to-hip ratio adjusted for BMI (age >50)
Waist-to-hip ratio adjusted for BMI x sex interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction
Waist-to-hip ratio adjusted for BMI x age interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)
Cerebrospinal fluid t-tau levels
Cerebrospinal fluid AB1-42 levels
Cerebrospinal fluid t-tau:AB1-42 ratio
Nicotine dependence
Pursuit maintenance gain in psychotic disorders
Initial pursuit acceleration
Pursuit maintenance gain
Anti-saccade response
Initial pursuit acceleration in psychotic disorders
Anti-saccade error rate in psychotic disorders
Nasopharyngeal carcinoma
Vaso-occlusive pain in sickle-cell anemia
Facial emotion recognition
Facial emotion recognition (happy faces)
Facial emotion recognition (sad faces)
Facial emotion recognition (angry faces)
Facial emotion recognition (fearful faces)
Nicotine metabolite ratio in current smokers
Hepatocellular carcinoma in hepatitis C infection
Primary biliary cirrhosis
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia
beta-nerve growth factor levels
Vascular endothelial growth factor levels
CTACK levels
Eotaxin levels
Fibroblast growth factor basic levels
Granulocyte-colony stimulating factor levels
Growth-regulated protein alpha levels
Hepatocyte growth factor levels
Interferon gamma levels
Interleukin-1-beta levels
Interleukin-1-receptor antagonist levels
Interleukin-2 levels
Interleukin-2 receptor antagonist levels
Interleukin-4 levels
Interleukin-5 levels
Interleukin-6 levels
Interleukin-7 levels
Interleukin-8 levels
Interleukin-9 levels
Interleukin-10 levels
Interleukin-13 levels
Interleukin-17 levels
Interleukin-18 levels
Macrophage Migration Inhibitory Factor levels
Interferon gamma-induced protein 10 levels
Breast cancer (estrogen-receptor negative)
Breast Cancer in BRCA1 mutation carriers
Extrinsic epigenetic age acceleration
Intrinsic epigenetic age acceleration
Major depression and alcohol dependence
Obstructive sleep apnea trait (apnea hypopnea index)
Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)
Obstructive sleep apnea during REM sleep (apnea hypopnea index)
Diastolic blood pressure x sodium interaction (1df test)
Systolic blood pressure x sodium interaction (2df test)
Diastolic blood pressure x sodium interaction (2df test)
Mean arterial pressure x sodium interaction (2df test)
Systolic blood pressure x sodium interaction (1df test)
Mean arterial pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (2df test)
Severe malaria (adjusted for sickle cell variant rs334)
Severe malaria
Late-onset Alzheimer's disease
Colorectal adenoma (advanced)
Colonoscopy-negative controls vs population controls
Paclitaxel disposition in epithelial ovarian cancer
Carboplatin disposition in epthelial ovarian cancer
Advanced age-related macular degeneration
Age-related macular degeneration (SNP x mitochondrial T5004C interaction)
Age-related macular degeneration (SNP x mitochondrial A4917G interaction)
Age-related macular degeneration (SNP x mitochondrial G12771A interaction)
Age-related macular degeneration (SNP x mitochondrial C16069T interaction)
Neuroblastoma (11q deletion)
Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)
Neuroblastoma (1p deletion)
Neuroblastoma (MYCN amplification)
Verbal memory performance (delayed recall level)
Verbal memory performance (residualized delayed recall change)
Verbal memory performance (immediate recall change)
Verbal memory performance (residualized delayed recall level)
Verbal memory performance (immediate recall level)
Verbal memory performance (delayed recall change)
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)
Systolic blood pressure (cigarette smoking interaction)
Diastolic blood pressure (cigarette smoking interaction)
Nodular sclerosis Hodgkin lymphoma
Mixed cellularity Hodgkin lymphoma
Hodgkin's lymphoma
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin
Tooth agenesis
Tooth agenesis (mandibular second premolars)
Tooth agenesis (maxillary lateral incisors)
Tooth agenesis (maxillary second premolars)
Pulse pressure (dietary potassium intake interaction)
Systolic blood pressure (dietary potassium intake interaction)
Diastolic blood pressure (dietary potassium intake interaction)
Mean arterial pressure (dietary potassium intake interaction)
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Idiopathic pulmonary fibrosis
Problematic alcohol use in trauma-exposed individuals
White coat effect (clinic systolic blood pressure minus home systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)
Alcohol consumption over the past year
"Allergic disease (asthma, hay fever or eczema)"
Type 2 diabetes
Atrial fibrillation
Incident atrial fibrillation
Prevalent atrial fibrillation
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)
Total mean fractional anisotropy measurement in first episode schizophrenia
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
Glomerular filtration rate (cystatin C)
Glomerular filtration rate (creatinine)
Smoking status (daily vs non-daily)
Smoking status (heavy vs light)
Smoking status (current vs former)
Smoking status (ever vs never smokers)
Peripheral arterial disease (traffic-related air pollution interaction)
Obstetric antiphospholipid syndrome
Breast cancer (survival)
Motor development (prenatal lead exposure interaction)
Mental development (prenatal lead exposure interaction)
Primary biliary cholangitis
Alcohol dependence
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis
Chronic alcoholic pancreatitis or alcohol-related cirrhosis
White blood cell count (eosinophil)
White blood cell count (lymphocyte)
White blood cell count (monocyte)
White blood cell count (neutrophil)
Prevalent type 2 diabetes
BMI (smoking interaction)
Waist circumference adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
BMI (adjusted for smoking behaviour)
Body mass index (joint analysis main effects and smoking interaction)
Waist circumference adjusted for BMI in non-smokers
Waist-to-hip ratio adjusted for BMI in smokers
BMI in non-smokers
Waist circumference adjusted for BMI in smokers
BMI in smokers
Waist-to-hip ratio adjusted for BMI in non-smokers
Attention deficit hyperactivity disorder and obsessive compulsive disorder
Residual cognition
"Facial morphology (factor 1, breadth of lateral portion of upper face)"
"Facial morphology (factor 10, width of nasal floor)"
"Facial morphology (factor 3, length of philtrum)"
"Facial morphology (factor 15, philtrum width)"
Facial morphology (factor 16)
"Facial morphology (factor 17, height of vermillion upper lip)"
Facial morphology (factor 18)
Facial morphology (factor 19)
Facial morphology (factor 20)
"Facial morphology (factor 2, vertical position of orbits relative to midface)"
"Facial morphology (factor 4, facial height related to vertical position of gnathion)"
"Facial morphology (factor 5, width of mouth relative to central midface)"
"Facial morphology (factor 6, height of vermillion lower lip)"
"Facial morphology (factor 7, width of cartilaginous portion of nose)"
"Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)"
"Facial morphology (factor 9, facial height related to vertical position of nasion)"
"Facial morphology (factor 11, projection of the nose)"
"Facial morphology (factor 12, vertical position of sublabial sulcus relative to central midface)"
"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)"
"Facial morphology (factor 14, intercanthal width)"
"Facial morphology (factor 21, depth of nasal alae)"
Facial morphology (factor 22)
Facial morphology (factor 23)
Alcohol consumption (drinks per week)
Alcohol consumption (drinkers vs non-drinkers)
Elevated serum prostate-specific antigen levels in healthy men
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)
Nevirapine-induced hypersensitivity in HIV (rash)
Nevirapine-induced hypersensitivity in HIV
Blood pressure traits (multi-trait analysis)
Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)
Lung cancer
Lung adenocarcinoma
Squamous cell lung carcinoma
Small cell lung carcinoma
Lung cancer in ever smokers
Lung cancer in never smokers
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Activities of daily living score
Short physical performance battery score
Mid-arm muscle circumference
Four meter walk test score
Cognitive performance
Calf circumference
Hand grip strength
Neurocognitive impairment in HIV-1 infection (continuous)
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder)
HIV-associated neurocognitive disorder
Neurocognitive impairment in HIV-1 infection (dichotomous)
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)
Aggressive periodontitis
Amyotrophic lateral sclerosis (sporadic)
Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms
Lipoprotein (a) levels
Alcohol consumption
Alcohol consumption in current drinkers
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)
Spontaneous preterm birth (maternal effect)
Knee osteoarthritis
Rate of cognitive decline in mild cognitive impairment (time interaction)
Heart rate variability traits (pvRSA/HF)
Craniofacial microsomia
Menopause (age at onset)
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma
Brunt stage in nonalcoholic fatty liver disease
Brunt grade in nonalcoholic fatty liver disease
Hepatocyte fat droplet content in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
"1,5-anhydroglucitol levels"
Myeloid white cell count
Lymphocyte counts
Immature fraction of reticulocytes
Neutrophil count
Basophil percentage of white cells
Lymphocyte percentage of white cells
Neutrophil percentage of white cells
Basophil percentage of granulocytes
Mean platelet volume
"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)"
Bronchial hyperresponsiveness in asthma
Serum sulfate level
Schizophrenia (age at onset)
Cutaneous squamous cell carcinoma
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
Modified Stumvoll Insulin Sensitivity Index
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)
Bone fracture in osteoporosis
Spontaneous dizygotic twinning
Alcoholic chronic pancreatitis
Sporadic neuroblastoma
"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)
Apolipoprotein A-IV levels
Language performance in older adults (adjusted for episodic memory)
Ankylosing spondylitis
Ankylosing spondylitis (SNP x SNP interaction)
Appendicular lean mass
Lean body mass
Blood pressure (parental or offspring effect)
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
Major depressive disorder
Tissue factor pathway inhibitor levels
Body mass index (adult)
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)
Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)
Tenofovir clearance in HIV infection
Bilirubin levels in tenofovir-treated HIV infection
Tacrolimus trough concentration in kidney transplant patients
Bone ultrasound measurement (velocity of sound)
Bone ultrasound measurement (broadband ultrasound attenuation)
Birth weight
Psychosis proneness (hypomanic personality scale)
Psychosis proneness (perceptual aberration scale)
Psychosis proneness (revised physical anhedonia scale)
Psychosis proneness (revised social anhedonia scale)
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)
Psychosis proneness (schizoidia scale)
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)
Sarcoidosis
Bone erosion in rheumatoid arthritis
Autism spectrum disorder or schizophrenia
Autism spectrum disorder
Energy expenditure (24h)
Resting metabolic rate
Breast cancer (estrogen-receptor positive)
Acute graft versus host disease in bone marrow transplantation (recipient effect)
Acute graft versus host disease in bone marrow transplantation (donor effect)
Coronary artery disease severity measurement
Chronic periodontitis (mean interproximal clinical attachment level)
Barrett's esophagus
Esophageal adenocarcinoma
Barrett's esophagus or Esophageal adenocarcinoma
Antisocial behavior
Resistance to antipsychotic treatment in schizophrenia
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)
Multiple sclerosis
Early onset atrial fibrillation
Conotruncal heart defects (inherited effects)
Left ventricular obstructive tract defect (inherited effect)
Conotruncal heart defects (maternal effects)
Left ventricular obstructive tract defect (maternal effect)
Congenital heart disease (inherited effect)
Congenital heart disease (maternal effect)
QRS duration
Achilles tendinopathy
Anterior cruciate ligament rupture
Neuropathy in taxane-treated breast cancer
Type 1 diabetes
Plasma trimethylamine N-oxide levels
Post bronchodilator FEV1 in COPD
Post bronchodilator FEV1/FVC ratio
Post bronchodilator FEV1
Post bronchodilator FEV1/FVC ratio in COPD
Pre bronchodilator FEV1
Pre bronchodilator FEV1/FVC ratio
Primary sclerosing cholangitis
"Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)"
Asthma
Response to statins (HDL cholesterol change)
Hypertriglyceridemia
Systemic lupus erythematosus
Survival in pancreatic cancer
Severe gingival inflammation
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy
QT interval (ambient particulate matter interaction)
Alopecia areata
Familial hepatitis B virus-related hepatocellular carcinoma
Petaloid toenail
Methotrexate-induced interstitial lung disease in rheumatoid arthritis
Celiac disease
Benign prostatic hyperplasia and/or lower urinary tract symptoms
Lumbar spine bone mineral density or breast cancer (pleiotropy)
Femoral neck bone mineral density or breast cancer (pleiotropy)
Foot ulcer in diabetes and neuropathy
Foot ulcer and neuropathy in diabetes
Iris color (b* coordinate)
Iris heterochromicity
Skin pigmentation
Iris color (L* coordinate)
Iris color (a* coordinate)
Visceral adipose tissue (sex interaction)
Subcutaneous adipose tissue (sex interaction)
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)
Visceral adipose tissue adjusted for BMI (sex interaction)
Alloimmunization response to pregnancy (HLA class I and II)
Alloimmunization response to pregnancy (HLA class I)
Alloimmunization response to pregnancy (HLA class II)
Alloimmunization response to pregnancy
Progranulin levels
Blood metabolite levels
Cognitive ability
Cognitive ability (MTAG)
Duloxetine response in major depressive disorder (remitter/non-remitter status)
Duloxetine response in major depressive disorder (responder/non-responder status)
Placebo response in major depressive disorder (remitter/non-remitter status)
Placebo response in major depressive disorder (responder/non-responder status)
Duloxetine response in major depressive disorder (% change in symptom score)
Placebo response in major depressive disorder (% change in symptom score)
Change in LVEF in response to paclitaxel in HER2+ breast cancer
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer
Lobe attachment (rater-scored or self-reported)
Lobe attachment (rater scored)
Early gestational weight gain (fetal effect)
Gestational weight gain (fetal effect)
Late gestational weight gain (fetal effect)
Early gestation weight gain (maternal effect)
Late gestational weight gain (maternal effect)
Gestational weight gain (maternal effect)
P wave terminal force
P wave duration
Mood instability
Thyroid stimulating hormone levels
Free thyroxine concentration
Caudate volume in trauma-exposed individuals
Nucleus accumbens volume in trauma-exposed individuals
Pallidum volume in trauma-exposed individuals
Amygdala volume in trauma-exposed individuals
Hippocampal volume in trauma-exposed individuals
Putamen volume in trauma-exposed individuals
Lateral ventricle volume in trauma-exposed individuals
Thalamus volume in trauma-exposed individuals
High altitude adaptation
Parkinson's disease
Parkinson's disease or schizophrenia
Carotid intima media thickness (mean)
Carotid intima media thickness (maximum)
Carotid intima media thickness (mean-maximum)
TPE interval (resting)
TPE interval (response to exercise)
TPE interval (recovery after exercise)
Serum immune biomarker levels
Cerebrospinal fluid immune biomarker levels
Bilirubin levels
Ulcerative colitis
White matter hyperintensity volume
Venous thromboembolism
OTU99_110 (Clostridiales) prevalence
OTU99_116 (Sutterella) prevalence
OTU99_12 (Bacteroides) prevalence
OTU99_120 (Ruminococcaceae) prevalence
OTU99_121 (Ruminococcaceae) prevalence
OTU99_123 (Phascolarctobacterium) prevalence
OTU99_124 (Paraprevotella) prevalence
OTU99_13 (Subdoligranulum) prevalence
OTU99_132 (Bacteroidales) prevalence
OTU99_137 (Ruminococcus) prevalence
OTU99_140 (Desulfovibrio) prevalence
OTU99_150 (Prevotella) prevalence
OTU99_155 (Butyrivibrio) prevalence
OTU99_157 (Barnesiella) prevalence
OTU99_16 (Faecalibacterium) prevalence
OTU99_166 (Prevotella) prevalence
OTU99_17 (Parabacteroides) prevalence
OTU99_171 (Bacteroides) prevalence
OTU99_19 (Bacteria) prevalence
OTU99_197 (Bacteroides) prevalence
OTU99_2 (Bacteroides) prevalence
OTU99_21 (Parasutterella) prevalence
OTU99_211 (Bacteroides) prevalence
OTU99_23 (Faecalibacterium) prevalence
OTU99_24 (Prevotella) prevalence
OTU99_8 (Ruminococcaceae) prevalence
OTU99_84 (Prevotella) prevalence
OTU99_85 (Alistipes) prevalence
OTU99_9 (Alistipes) prevalence
OTU99_92 (Ruminococcus) prevalence
OTU99_94 (Bacteroides) prevalence
OTU99_98 (Phascolarctobacterium) prevalence
TestASV_1 (Bacteroides) prevalence
TestASV_10 (Parabacteroides) prevalence
TestASV_11 (Lachnospiraceae) prevalence
TestASV_12 (Bacteroides) prevalence
TestASV_13 (Bacteroides) prevalence
TestASV_14 (Lachnospiraceae) prevalence
TestASV_15 (Bacteroides) prevalence
TestASV_16 (Bacteroides) prevalence
TestASV_17 (Bacteroides) prevalence
TestASV_18 (Prevotella) prevalence
TestASV_19 (Prevotella) prevalence
TestASV_2 (Bacteroides) prevalence
C_Actinobacteria abundance
C_Alphaproteobacteria abundance
C_Bacteroidia abundance
C_Betaproteobacteria abundance
C_Clostridia abundance
C_Erysipelotrichia abundance
G_Holdemanella abundance
G_Lachnospiraceae abundance
G_Oscillibacter abundance
G_Parabacteroides abundance
G_Paraprevotella abundance
G_Parasutterella abundance
G_Phascolarctobacterium abundance
G_Porphyromonadaceae abundance
G_Prevotella abundance
G_Prevotellaceae abundance
G_Roseburia abundance
G_Ruminococcaceae abundance
G_Ruminococcus abundance
G_Ruminococcus2 abundance
G_Subdoligranulum abundance
G_Sutterella abundance
O_Bacteroidales abundance
O_Burkholderiales abundance
TestASV_20 (Phascolarctobacterium) prevalence
TestASV_21 (Ruminococcaceae) prevalence
TestASV_22 (Sutterella) prevalence
TestASV_23 (Barnesiella) prevalence
TestASV_24 (Bacteroides) prevalence
TestASV_25 (Sutterella) prevalence
TestASV_26 (Phascolarctobacterium) prevalence
C_Gammaproteobacteria abundance
C_Negativicutes abundance
F_Acidaminococcaceae abundance
F_Bacteroidaceae abundance
F_Coriobacteriaceae abundance
F_Erysipelotrichaceae abundance
F_Lachnospiraceae abundance
F_Porphyromonadaceae abundance
F_Prevotellaceae abundance
F_Rikenellaceae abundance
F_Ruminococcaceae abundance
F_Sutterellaceae abundance
G_Alistipes abundance
G_Alloprevotella abundance
G_Alphaproteobacteria abundance
G_Bacteroidales abundance
G_Bacteroides abundance
G_Bacteroidetes abundance
G_Barnesiella abundance
G_Catenibacterium abundance
G_Clostridiales abundance
G_Clostridium_XlVa abundance
G_Coprococcus abundance
G_Faecalibacterium abundance
G_Firmicutes abundance
TestASV_32 (Ruminococcaceae) prevalence
TestASV_33 (Paraprevotella) prevalence
TestASV_34 (Phascolarctobacterium) prevalence
TestASV_35 (Alphaproteobacteria) prevalence
TestASV_36 (Aestuariispira) prevalence
TestASV_37 (Ruminococcaceae) prevalence
TestASV_38 (Ruminococcus) prevalence
TestASV_39 (Bacteroides) prevalence
TestASV_4 (Alistipes) prevalence
TestASV_40 (Barnesiella) prevalence
TestASV_41 (Barnesiella) prevalence
TestASV_42 (Alphaproteobacteria) prevalence
TestASV_43 (Parasutterella) prevalence
TestASV_44 (Parasutterella) prevalence
TestASV_45 (Clostridiales) prevalence
TestASV_46 (Sutterella) prevalence
TestASV_47 (Parasutterella) prevalence
TestASV_48 (Sutterella) prevalence
TestASV_49 (Parasutterella) prevalence
TestASV_27 (Ruminococcaceae) prevalence
TestASV_28 (Holdemanella) prevalence
TestASV_29 (Barnesiella) prevalence
TestASV_3 (Bacteroides) prevalence
TestASV_30 (Paraprevotella) prevalence
TestASV_31 (Ruminococcus) prevalence
TestASV_5 (Bacteroides) prevalence
TestASV_6 (Subdoligranulum) prevalence
TestASV_7 (Bacteroides) prevalence
TestASV_8 (Bacteroides) prevalence
TestASV_9 (Alistipes) prevalence
Brain imaging measurements (variance)
Brain imaging measurements (mean)
Gastrointestinal infection
Idiopathic downbeat nystagmus
Membranous nephropathy
Chronic obstructive pulmonary disease
Physiological dysregulation (Mahalanobis distance)
Hand grip strength (Mahalanobis distance)
Neck pain or shoulder pain
HDL cholesterol levels
OTU97_16 (Faecalibacterium) abundance
O_Coriobacteriales abundance
OTU97_165 (Porphyromonadaceae) abundance
O_Selenomonadales abundance
OTU97_173 (Bacteroides) abundance
OTU97_100 (Ruminococcaceae) abundance
OTU97_2 (Bacteroides) abundance
OTU97_102 (Prevotella) abundance
OTU97_23 (Faecalibacterium) abundance
OTU97_106 (Ruminococcaceae) abundance
OTU97_24 (Prevotella) abundance
OTU97_108 (Phascolarctobacterium) abundance
OTU97_109 (Paraprevotella) abundance
OTU97_11 (Parabacteroides) abundance
OTU97_277 (Prevotella) abundance
OTU97_117 (Ruminococcus) abundance
OTU97_30 (Roseburia) abundance
OTU97_12 (Bacteroides) abundance
OTU97_33 (Holdemanella) abundance
OTU97_34 (Ruminococcus) abundance
OTU97_130 (Butyrivibrio) abundance
OTU97_38 (Alphaproteobacteria) abundance
OTU97_138 (Oscillibacter) abundance
OTU97_4 (Alistipes) abundance
OTU97_15 (Parasutterella) abundance
O_Clostridiales abundance
OTU97_163 (Bacteroides) abundance
O_Erysipelotrichales abundance
OTU97_17 (Parabacteroides) abundance
OTU97_1 (Bacteroides) abundance
OTU97_19 (Bacteria) abundance
OTU97_101 (Sutterella) abundance
OTU97_21 (Parasutterella) abundance
OTU97_105 (Ruminococcaceae) abundance
OTU97_235 (Phascolarctobacterium) abundance
OTU97_257 (Mitsuokella) abundance
OTU97_26 (Parasutterella) abundance
OTU97_27 (Bacteroides) abundance
OTU97_113 (Bacteroidales) abundance
OTU97_3 (Bacteroides) abundance
OTU97_119 (Desulfovibrio) abundance
OTU97_31 (Prevotella) abundance
OTU97_126 (Prevotella) abundance
OTU97_13 (Subdoligranulum) abundance
OTU97_354 (Alloprevotella) abundance
OTU97_137 (Catenibacterium) abundance
OTU97_39 (Proteobacteria) abundance
OTU97_140 (Bacteroides) abundance
OTU97_46 (Lachnospiraceae) abundance
OTU97_150 (Bacteroides) abundance
OTU99_12 (Bacteroides) abundance
OTU99_120 (Ruminococcaceae) abundance
OTU99_121 (Ruminococcaceae) abundance
OTU99_123 (Phascolarctobacterium) abundance
OTU99_124 (Paraprevotella) abundance
OTU99_13 (Subdoligranulum) abundance
OTU99_132 (Bacteroidales) abundance
OTU99_137 (Ruminococcus) abundance
OTU99_140 (Desulfovibrio) abundance
OTU99_150 (Prevotella) abundance
OTU99_155 (Butyrivibrio) abundance
OTU99_157 (Barnesiella) abundance
OTU99_16 (Faecalibacterium) abundance
OTU99_166 (Prevotella) abundance
OTU99_17 (Parabacteroides) abundance
OTU99_171 (Bacteroides) abundance
OTU99_19 (Bacteria) abundance
OTU99_197 (Bacteroides) abundance
OTU99_2 (Bacteroides) abundance
OTU99_21 (Parasutterella) abundance
OTU99_211 (Bacteroides) abundance
OTU99_23 (Faecalibacterium) abundance
P_Actinobacteria abundance
OTU99_24 (Prevotella) abundance
OTU99_26 (Parasutterella) abundance
OTU99_271 (Prevotella) abundance
OTU99_298 (Phascolarctobacterium) abundance
OTU99_3 (Bacteroides) abundance
OTU99_30 (Parasutterella) abundance
OTU99_32 (Prevotella) abundance
OTU99_34 (Holdemanella) abundance
OTU99_35 (Ruminococcus) abundance
OTU99_39 (Alphaproteobacteria) abundance
OTU99_4 (Alistipes) abundance
OTU99_40 (Proteobacteria) abundance
OTU99_45 (Faecalibacterium) abundance
OTU99_47 (Prevotella) abundance
OTU99_5 (Sutterella) abundance
OTU99_53 (Aestuariispira) abundance
OTU99_54 (Holdemanella) abundance
OTU99_55 (Barnesiella) abundance
OTU99_558 (Bacteroidales) abundance
OTU99_58 (Bacteroides) abundance
OTU99_59 (Prevotella) abundance
OTU99_6 (Sutterella) abundance
OTU99_62 (Ruminococcaceae) abundance
OTU99_65 (Sutterellaceae) abundance
OTU99_7 (Lachnospiraceae) abundance
OTU99_72 (Parabacteroides) abundance
OTU99_78 (Clostridiales) abundance
OTU97_5 (Sutterella) abundance
OTU97_50 (Aestuariispira) abundance
OTU97_51 (Barnesiella) abundance
OTU97_53 (Bacteroides) abundance
OTU97_56 (Ruminococcaceae) abundance
OTU97_58 (Sutterellaceae) abundance
OTU97_6 (Sutterella) abundance
OTU97_65 (Parabacteroides) abundance
OTU97_69 (Clostridiales) abundance
OTU97_7 (Lachnospiraceae) abundance
OTU97_73 (Prevotella) abundance
OTU97_74 (Alistipes) abundance
OTU97_8 (Ruminococcaceae) abundance
OTU97_80 (Ruminococcus) abundance
OTU97_82 (Bacteroides) abundance
OTU97_86 (Phascolarctobacterium) abundance
OTU97_9 (Alistipes) abundance
OTU97_95 (Cytophagales) abundance
OTU97_97 (Clostridiales) abundance
OTU99_1 (Bacteroides) abundance
OTU99_106 (Barnesiella) abundance
OTU99_108 (Cytophagales) abundance
OTU99_11 (Parabacteroides) abundance
OTU99_110 (Clostridiales) abundance
OTU99_116 (Sutterella) abundance
Hallux valgus
Meat-related diet
Pork consumption
Poultry consumption
Raw vegetable consumption
Cooked vegetable consumption
Fruit consumption
Oily fish consumption
Non-oily fish consumption
Lamb consumption
Processed meat consumption
Fish- and plant-related diet
Beef consumption
Basophil count
Polycystic ovary syndrome (reproductive subtype)
Polycystic ovary syndrome (metabolic subtype)
Polycystic ovary syndrome (indeterminate subtype)
High-altitude pulmonary edema
Peak weight velocity
Age at adiposity peak
BMI at adiposity peak
Age at adiposity rebound
BMI at adiposity rebound
Peak height velocity
Chronic postoperative pain
Obsessive compulsive disorder severity
Compulsion score in obsessive compulsive disorder
Obsession score in obsessive compulsive disorder
Parkinson's disease (age of onset)
Adiponectin levels
Aortic valve area
Ebbinghaus illusion (underestimation)
Ebbinghaus illusion (overestimation)
Hematological and biochemical traits
Lung function
Cholesterol
Physiological traits
Metabolic syndrome
Low HDL-cholesterol levels
High fasting blood glucose
Heart failure
Graft survival time in renal transplantation (donor effect)
Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction
Salivary metabolite levels
LDL cholesterol levels
Alanine aminotransferase levels
Hemoglobin A1c levels
Hip circumference
Midline nonsyndromic craniosynostosis
Metopic nonsyndromic craniosynostosis
fetal weight (maternal genotype effect)
Bone mineral density or trunk lean mass (pleiotropy)
Trunk lean mass
Bone mineral density
Anxiety
Anxiety disorders
LDL cholesterol change in response to niacin in statin-treated individuals
Triglycerides levels in response to niacin in statin-treated individuals
Total cholesterol change in response to niacin in statin-treated individuals
Lipoprotein (a) levels in response to niacin in statin-treated individuals
HDL cholesterol change in response to niacin in statin-treated individuals
Adult onset Still's disease
Renal underexcretion gout
Renal overload gout
Gout (combined type)
Gout (normal type)
Voxel-wise structural brain imaging measurements in Alzheimer’s disease
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
Lifetime smoking index
Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Systolic blood pressure response to chlorthalidone in hypertension
Diastolic blood pressure response to chlorthalidone in hypertension
Refractive error
Smoking initiation (ever regular vs never regular)
Smoking cessation (former vs current smokers)
Smoking behaviour (cigarettes smoked per day)
Age of smoking initiation
G_Prevotella prevalence
G_Prevotellaceae prevalence
G_Ruminococcus prevalence
G_Sutterella prevalence
O_Selenomonadales prevalence
OTU97_1 (Bacteroides) prevalence
OTU97_100 (Ruminococcaceae) prevalence
OTU97_101 (Sutterella) prevalence
OTU97_102 (Prevotella) prevalence
OTU97_105 (Ruminococcaceae) prevalence
OTU97_106 (Ruminococcaceae) prevalence
OTU97_108 (Phascolarctobacterium) prevalence
OTU97_109 (Paraprevotella) prevalence
OTU97_11 (Parabacteroides) prevalence
OTU97_113 (Bacteroidales) prevalence
OTU97_117 (Ruminococcus) prevalence
OTU97_119 (Desulfovibrio) prevalence
OTU97_12 (Bacteroides) prevalence
OTU97_126 (Prevotella) prevalence
OTU97_13 (Subdoligranulum) prevalence
OTU97_130 (Butyrivibrio) prevalence
OTU97_137 (Catenibacterium) prevalence
OTU97_138 (Oscillibacter) prevalence
OTU97_140 (Bacteroides) prevalence
OTU99_30 (Parasutterella) prevalence
OTU99_26 (Parasutterella) prevalence
OTU99_271 (Prevotella) prevalence
OTU99_298 (Phascolarctobacterium) prevalence
OTU99_3 (Bacteroides) prevalence
OTU99_32 (Prevotella) prevalence
OTU99_34 (Holdemanella) prevalence
OTU99_35 (Ruminococcus) prevalence
OTU99_39 (Alphaproteobacteria) prevalence
OTU99_4 (Alistipes) prevalence
OTU99_40 (Proteobacteria) prevalence
OTU99_45 (Faecalibacterium) prevalence
OTU99_47 (Prevotella) prevalence
OTU99_5 (Sutterella) prevalence
OTU99_53 (Aestuariispira) prevalence
OTU99_54 (Holdemanella) prevalence
OTU99_55 (Barnesiella) prevalence
OTU99_558 (Bacteroidales) prevalence
OTU99_58 (Bacteroides) prevalence
OTU99_59 (Prevotella) prevalence
OTU99_6 (Sutterella) prevalence
OTU99_62 (Ruminococcaceae) prevalence
OTU99_65 (Sutterellaceae) prevalence
OTU99_7 (Lachnospiraceae) prevalence
OTU99_72 (Parabacteroides) prevalence
OTU99_78 (Clostridiales) prevalence
OTU99_8 (Ruminococcaceae) abundance
OTU99_84 (Prevotella) abundance
OTU99_85 (Alistipes) abundance
OTU99_9 (Alistipes) abundance
OTU99_92 (Ruminococcus) abundance
OTU99_94 (Bacteroides) abundance
OTU99_98 (Phascolarctobacterium) abundance
P_Bacteroidetes abundance
P_Firmicutes abundance
P_Proteobacteria abundance
TestASV_1 (Bacteroides) abundance
TestASV_10 (Parabacteroides) abundance
TestASV_11 (Lachnospiraceae) abundance
TestASV_12 (Bacteroides) abundance
TestASV_13 (Bacteroides) abundance
TestASV_14 (Lachnospiraceae) abundance
TestASV_15 (Bacteroides) abundance
TestASV_16 (Bacteroides) abundance
TestASV_17 (Bacteroides) abundance
TestASV_18 (Prevotella) abundance
TestASV_19 (Prevotella) abundance
TestASV_2 (Bacteroides) abundance
TestASV_20 (Phascolarctobacterium) abundance
TestASV_21 (Ruminococcaceae) abundance
TestASV_22 (Sutterella) abundance
TestASV_47 (Parasutterella) abundance
TestASV_48 (Sutterella) abundance
TestASV_49 (Parasutterella) abundance
TestASV_5 (Bacteroides) abundance
TestASV_6 (Subdoligranulum) abundance
TestASV_7 (Bacteroides) abundance
TestASV_8 (Bacteroides) abundance
TestASV_9 (Alistipes) abundance
C_Alphaproteobacteria prevalence
C_Negativicutes prevalence
F_Acidaminococcaceae prevalence
F_Prevotellaceae prevalence
G_Alloprevotella prevalence
G_Alphaproteobacteria prevalence
G_Bacteroidales prevalence
G_Bacteroidetes prevalence
G_Barnesiella prevalence
G_Catenibacterium prevalence
G_Coprococcus prevalence
G_Holdemanella prevalence
G_Parabacteroides prevalence
G_Paraprevotella prevalence
G_Parasutterella prevalence
G_Phascolarctobacterium prevalence
G_Porphyromonadaceae prevalence
OTU97_4 (Alistipes) prevalence
OTU97_46 (Lachnospiraceae) prevalence
OTU97_5 (Sutterella) prevalence
OTU97_50 (Aestuariispira) prevalence
OTU97_51 (Barnesiella) prevalence
OTU97_53 (Bacteroides) prevalence
OTU97_56 (Ruminococcaceae) prevalence
OTU97_58 (Sutterellaceae) prevalence
OTU97_6 (Sutterella) prevalence
OTU97_65 (Parabacteroides) prevalence
OTU97_69 (Clostridiales) prevalence
OTU97_7 (Lachnospiraceae) prevalence
OTU97_73 (Prevotella) prevalence
OTU97_74 (Alistipes) prevalence
OTU97_8 (Ruminococcaceae) prevalence
OTU97_80 (Ruminococcus) prevalence
OTU97_82 (Bacteroides) prevalence
OTU97_86 (Phascolarctobacterium) prevalence
OTU97_9 (Alistipes) prevalence
OTU97_95 (Cytophagales) prevalence
OTU97_97 (Clostridiales) prevalence
OTU99_1 (Bacteroides) prevalence
OTU99_106 (Barnesiella) prevalence
OTU99_108 (Cytophagales) prevalence
OTU99_11 (Parabacteroides) prevalence
TestASV_23 (Barnesiella) abundance
TestASV_24 (Bacteroides) abundance
TestASV_25 (Sutterella) abundance
TestASV_26 (Phascolarctobacterium) abundance
TestASV_27 (Ruminococcaceae) abundance
TestASV_28 (Holdemanella) abundance
TestASV_29 (Barnesiella) abundance
TestASV_3 (Bacteroides) abundance
TestASV_30 (Paraprevotella) abundance
TestASV_31 (Ruminococcus) abundance
TestASV_32 (Ruminococcaceae) abundance
TestASV_33 (Paraprevotella) abundance
TestASV_34 (Phascolarctobacterium) abundance
TestASV_35 (Alphaproteobacteria) abundance
TestASV_36 (Aestuariispira) abundance
TestASV_37 (Ruminococcaceae) abundance
TestASV_38 (Ruminococcus) abundance
TestASV_39 (Bacteroides) abundance
TestASV_4 (Alistipes) abundance
TestASV_41 (Barnesiella) abundance
TestASV_42 (Alphaproteobacteria) abundance
TestASV_43 (Parasutterella) abundance
TestASV_44 (Parasutterella) abundance
TestASV_45 (Clostridiales) abundance
TestASV_46 (Sutterella) abundance
OTU97_15 (Parasutterella) prevalence
OTU97_150 (Bacteroides) prevalence
OTU97_16 (Faecalibacterium) prevalence
OTU97_163 (Bacteroides) prevalence
OTU97_165 (Porphyromonadaceae) prevalence
OTU97_17 (Parabacteroides) prevalence
OTU97_173 (Bacteroides) prevalence
OTU97_19 (Bacteria) prevalence
OTU97_2 (Bacteroides) prevalence
OTU97_21 (Parasutterella) prevalence
OTU97_23 (Faecalibacterium) prevalence
OTU97_235 (Phascolarctobacterium) prevalence
OTU97_24 (Prevotella) prevalence
OTU97_257 (Mitsuokella) prevalence
OTU97_26 (Parasutterella) prevalence
OTU97_27 (Bacteroides) prevalence
OTU97_277 (Prevotella) prevalence
OTU97_3 (Bacteroides) prevalence
OTU97_30 (Roseburia) prevalence
OTU97_31 (Prevotella) prevalence
OTU97_33 (Holdemanella) prevalence
OTU97_34 (Ruminococcus) prevalence
OTU97_354 (Alloprevotella) prevalence
OTU97_38 (Alphaproteobacteria) prevalence
OTU97_39 (Proteobacteria) prevalence
Bipolar disorder or body mass index
Bipolar disorder or type 2 diabetes
Survival in breast cancer (estrogen-receptor positive)
Childhood maltreatment
Body fat percentage
Fat-free mass
High density lipoprotein cholesterol levels
Diastolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
HDL cholesterol levels in current smokers
HDL cholesterol levels in non smokers
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
HDL cholesterol levels in ever smokers
HDL cholesterol levels in never smokers
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
LDL cholesterol levels in current smokers
LDL cholesterol levels in non smokers
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
LDL cholesterol levels in ever smokers
LDL cholesterol levels in never smokers
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)
Triglyceride levels in current smokers
Triglyceride levels in non smokers
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)
Triglyceride levels in ever smokers
Triglyceride levels in never smokers
Substance uses or psychiatric disorders (pleiotropy)
Relative fat intake
Relative protein intake
Relative carbohydrate intake
Relative sugar intake
Vertical cup-disc ratio (adjusted for vertical disc diameter)
Vertical cup-disc ratio (multi-trait analysis)
Intraocular pressure
Glaucoma
Glaucoma (multi-trait analysis)
Ischemic stroke
Intracerebral hemorrhage
Left ventricular ejection fraction
Depression
Post-traumatic stress disorder
Suicidal or self-harm ideation
Refractive error (age-at-onset of spectacle wearing-inferred)
Refractive error (autorefraction measured)
Cardioembolic stroke (CCSp classification)
Cardioembolic stroke (TOAST classification)
Cardioembolic stroke (CCS and TOAST classification)
Cardioembolic stroke (CCS or TOAST classification)
Large artery stroke (CCSc classification)
Large artery stroke (CCSp classification)j
Large artery stroke (TOAST classification)
Large artery stroke (CCS and TOAST classification)
Large artery stroke (CCS or TOAST classification)
Small vessel stroke (CCSc classification)
Small vessel stroke (CCSp classification)
Small vessel stroke (TOAST classification)
Small vessel stroke (CCS and TOAST classification)
Small vessel stroke (CCS or TOAST classification)
Cardioembolic stroke (CCSc classification)
Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker
Externalizing behaviour score
"Multiple traits (2,148)"
"Multiple traits (2,173)"
Basal ganglia growth
White matter growth
Cerebellum growth
Cerebral cortical growth
Right lateral prefrontal cortical growth
Hirschsprung disease
Death
Cancer
Coronary heart disease
Diabetes mellitus
Stroke
Blood glucose levels
Infective endocarditis in Staphylococcus aureus infection
Insomnia
Huntington's disease (age at onset)
Glioma
Glioblastoma
Non-glioblastoma glioma
Apolipoprotein B levels
Apolipoprotein A1 levels
Cerebrospinal fluid beta-site APP cleaving enzyme levels
Plasma neurofilament light levels
Exfoliation syndrome
Hippocampal atrophy rate
Nucleus accumbens volume
Amygdala volume
Brainstem volume
Caudate nucleus volume
Pallidum volume
Putamen volume
Thalamus volume
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-B
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Cortical surface area (visual PC2)
Cortical thickness (PC1)
Cortical thickness (PC2)
Cortical surface area (global PC1)
"19,155 disease classifications in UK Biobank (pleiotropy)"
Complement factor H binding to malondialdehyde
Vascular endothelial growth factor levels in major depressive disorder
Buruli ulcer
Buruli ulcer (age at onset)
COVID-19 (very severe respiratory confirmed vs not hospitalized) RELEASE 4
COVID-19 (RELEASE 5)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 3
COVID-19 (hospitalized vs not hospitalized) RELEASE 3
COVID-19 (hospitalized vs population) RELEASE 3
COVID-19 (covid vs lab/self reported negative) RELEASE 3
COVID-19 (RELEASE 3)
COVID-19 (predicted from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 3
COVID-19 (very severe respiratory confirmed vs population) RELEASE 5
COVID-19 (hospitalized vs not hospitalized) RELEASE 5
COVID-19 (hospitalized vs population) RELEASE 5
COVID-19 (RELEASE 4)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 4
COVID-19 (hospitalized covid vs not hospitalized) RELEASE 4
COVID-19 (predicted covid from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 4
Neuroblastoma or malignant cutaneous melanoma
Cotinine and 3'-hydroxycotinine levels in current smokers
Cotinine levels in current smokers
Smoking behaviour (cigarette pack-years)
Smoking intensity (cotinine levels/cigarettes per day)
COVID-19 (hospitalized vs population) RELEASE 4
COVID-19 (covid vs lab/self reported negative) RELEASE 4
Corneal astigmatism
Refractive astigmatism
Eye color (saturation)
Eye color
Hair color
Eye color (brightness)
Eye color (hue)
"Skin, hair and eye pigmentation (multivariate analysis)"
Intracranial aneurysm
Uric acid elevation in response to thiazide-like diuretic in hypertension
Lifetime anxiety disorder
Anxiety symptoms
Maternal nondisjunction of chromosome 21 (mothers vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs fathers)
Maternal nondisjunction of chromosome 21 (MII error vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs MII error)
T-cell acute lymphoblastic leukaemia
Cerebrospinal fluid neurofilament light levels
Serum metabolite levels (CMS)
Change in serum metabolite levels
Change in serum metabolite levels (CMS)
Serum metabolite levels
Hepatocellular carcinoma in hepatitis B infection
Chronic kidney disease
Myocardial infarction
Red blood cell traits (multivariate analysis)
Parkinson's disease or first degree relation to individual with Parkinson's disease
Skin pigmentation (conditioned on rs1426654 and rs35397)
Kidney stones
Disability (impaired activities of daily living)
LDL cholesterol levels x loop diuretics use interaction
Triglyceride levels x loop diuretics use interaction
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
Triglyceride levels x thiazide or thiazide-like diuretics use interaction
HDL cholesterol levels x loop diuretics use interaction
Response to antiepileptic drugs in genetic generalized epilepsy
Response to valproic acid in genetic generalized epilepsy
Response to lamotrigine in genetic generalized epilepsy
Response to levetiracetam in genetic generalized epilepsy
Response to lamotrigine and valproic acid in genetic generalized epilepsy
Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide)
Levodopa wearing off effect (motor symptom score change) in Parkinson's disease (response to zonisamide)
Neuritic plaque
Neurofibrillary tangles
Diffuse plaques
Cerebral amyloid angiopathy
Microscopic brain infarct
Macroscopic brain infarct
Dementia with Lewy bodies
Neuropathologic traits (pleiotropy)
Nucleoside diphosphate kinase A levels in hepatocellular carcinoma
Hallucinations in long-term cannabis use
Severe malarial anemia in Plasmodium falciparum infection
Cryptosporidiosis
Airflow obstruction in ever smokers
Sitting height
Calcium levels
Chloride levels
Iron levels
Magnesium levels
Potassium levels
Sodium levels
Bicarbonate levels
Creatine kinase levels
Activated partial thromboplastin time
Prothrombin time
International normalisation ratio
Fibrinogen
Triglycerides
Serum total protein level
C-peptide levels
Pro B-type natriuretic peptide
Iron status biomarkers (total iron binding capacity)
Unsaturated iron binding capacity
Total bilirubin levels
Uric acid levels
Serum folate levels
Serum creatinine levels
Homocysteine levels
Vitamin B12 levels
Spontaneous coronary artery dissection
Drug-induced liver injury in interferon-beta-treated multiple sclerosis
Current cigarettes per day in chronic obstructive pulmonary disease
Circulating odd-numbered chain saturated fatty acid levels (C15:0)
Circulating odd-numbered chain saturated fatty acid levels (C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C19:0)
Circulating odd-numbered chain saturated fatty acid levels (C23:0)
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease
White matter integrity (fractional anisotropy)
White matter integrity (mean diffusivity)
Stroke and BMI (pleiotropy)
NASH resolution in nonalcoholic steatohepatitis
Pruritus in nonalcoholic steatohepatitis
Fibrosis improvement in nonalcoholic steatohepatitis
Cirrhosis
IgA nephropathy
Body fat distribution (arm fat ratio)
Body fat distribution (leg fat ratio)
Body fat distribution (trunk fat ratio)
Opioid use cessation
Bipolar disorder or major depressive disorder
Serum total polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome
Serum docosahexaenoic fatty acid concentration in metabolic syndrome
Serum linoleic acid concentration in metabolic syndrome
Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome
Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome
Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome
Renal complication in type 2 diabetes
Acute respiratory distress syndrome in sepsis
Urate levels
Glycemic traits (multi-trait analysis)
Prostate cancer aggressiveness (high vs low)
Prostate cancer aggressiveness (high vs low/intermediate)
Prostate cancer (advanced vs non-advanced)
Prostate cancer (advanced)
Prostate cancer (early onset)
Prostate cancer (Gleason score)
Inhibin B levels
Semen volume
Sperm concentration
Testis size
Automobile speeding propensity
Number of sexual partners
General risk tolerance (MTAG)
Risk-taking tendency (4-domain principal component model)
General risk tolerance
Adventurousness
Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Serum sclerostin levels
Leisure sedentary behaviour (television watching)
Leisure sedentary behaviour (computer use)
Driving (hours per day)
White matter hyperintensities
Cutaneous malignant melanoma
Cutaneous melanoma or hair colour
Nevus count or cutaneous melanoma
Breslow thickness in cutaneous melanoma
QT interval
JT interval
Bipolar disorder or intelligence (pleiotropy)
Schizophrenia or intelligence (pleiotropy)
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Plasma free amino acid levels (adjusted for one other PFAA)
Plasma free proline levels
Plasma free asparagine levels
Plasma free amino acid levels
Lung function in heavy smokers (low FEV1 vs high FEV1)
Lung function in never smokers (high FEV1 vs average FEV1)
Lung function in heavy smokers (high FEV1 vs average FEV1)
Lung function in never smokers (low FEV1 vs average FEV1)
Lung function in heavy smokers (low FEV1 vs average FEV1)
Smoking status (heavy vs never)
Lung function (low FEV1 vs high FEV1) x smoking interaction
Lung function (low FEV1 vs high FEV1)
Lung function in never smokers (low FEV1 vs high FEV1)
Cortical thickness
Narcolepsy with cataplexy
Male-pattern baldness
Sclerostin levels
Scavenger receptor cysteine-rich domain-containing group B protein levels
Sulfatase-modifying factor 2 levels
Trefoil factor 2 levels
Thimet oligopeptidase levels
Thyrotropin subunit beta levels
Thioredoxin domain-containing protein 5 levels
Thymidine phosphorylase levels
Tyrosine-protein kinase receptor TYRO3 levels
Ubiquitin carboxyl-terminal hydrolase 8 levels
Versican core protein levels
Angiotensin-converting enzyme 2 levels
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels
Agouti-related protein levels
Protein AMBP levels
Angiopoietin-1 levels
Bone morphogenetic protein 6 levels
Brother of CDO levels
"Carbonic anhydrase 5A,mitochondrial levels"
C-C motif chemokine 17 levels
C-C motif chemokine 3 levels
T-cell surface glycoprotein CD4 levels
CD40 ligand levels
SLAM family member 5 levels
Carcinoembryonic antigenrelated cell adhesion molecule 8 levels
C-type lectin domain family 5 member A levels
CXADR-like membrane protein levels
Calsyntenin-2 levels
Clusterin-like protein 1 levels
Catechol O-methyltransferase levels
Crk-like protein levels
Pro-cathepsin H levels
Cathepsin O levels
Aromatic-L-amino-acid decarboxylase levels
Dipeptidyl peptidase 2 levels
Gamma-enolase levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels
Ectonucleoside triphosphate diphosphohydrolase 5 levels
Protein FAM3C levels
"Fructose-1,6-bisphosphatase 1 levels"
Fc receptor-like protein 1 levels
Peptidyl-prolyl cis-trans isomerase FKBP4 levels
Galanin peptide levels
Glutaredoxin-1 levels
GRB2-related adapter protein 2 levels
Insulin-like growth factor-binding protein-like 1 levels
Integrin beta-7 levels
Kallikrein-10 levels
Kynurenine-oxoglutarate transaminase 1 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Leucine-rich repeats and immunoglobulin-like domains protein 1 levels
Low-density lipoprotein receptor-related protein 11 levels
Multiple coagulation factor deficiency protein 2 levels
Meprin A subunit beta levels
Meteorin-like protein levels
NAD kinase levels
Nectin-2 levels
Nodal modulator 1 levels
Neural proliferation differentiation and control protein 1 levels
Neuronal pentraxin receptor levels
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 levels
Paired immunoglobulin-like type 2 receptor beta levels
Protein phosphatase inhibitor 2 levels
Dihydropteridine reductase levels
Regenerating islet-derived protein 4 levels
Eosinophil cationic protein levels
Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels
Reticulon-4 receptor levels
Protein S100-A12 levels
Syndecan-4 levels
Semaphorin-3F levels
Serpin B6 levels
Serpin B8 levels
Sialic acid-binding Ig-like lectin 7 levels
Synaptosomal-associated protein 23 levels
Tartrate-resistant acid phosphatase type 5 levels
Urokinase-type plasminogen activator levels
Urokinase plasminogen activator surface receptor levels
vWF levels
Lysophosphatidic acid phosphatase type 6 levels
Adhesion G protein-coupled receptor E2 levels
Adhesion G-protein coupled receptor G2 levels
Retinal dehydrogenase 1 levels
Angiopoietin-2 levels
Angiopoietin-related protein 1 levels
Angiopoietin-related protein 7 levels
DNA-(apurinic or apyrimidinic site) lyase levels
Amyloid-like protein 1 levels
Arginase-1 levels
Large proline-rich protein BAG6 levels
Carbonic anhydrase 13 levels
Soluble calcium-activated nucleotidase 1 levels
Coiled-coil domain-containing protein 80 levels
Sialomucin core protein 24 levels
T-cell surface glycoprotein CD1c levels
CD2-associated protein levels
B-cell antigen receptor complex-associated protein beta chain levels
Cadherin-2 levels
Cadherin-related family member 5 levels
Chordin-like protein 2 levels
Chymotrypsin C levels
Cathepsin L1 levels
C-X-C motif chemokine 1 levels
Decorin levels
"2,4-dienoyl-CoA reductase,mitochondrial levels"
Dickkopf-related protein 1 levels
"Fatty acid-binding protein,intestinal levels"
Fibroblast growth factor 21 levels
Fibroblast growth factor 23 levels
Follistatin levels
Galectin-9 levels
Growth/differentiation factor 2 levels
Growth hormone levels
Gastric intrinsic factor levels
Lactoylglutathione lyase levels
Gastrotropin levels
Hydroxyacid oxidase 1 levels
Proheparin-binding EGF-like growth factor levels
Heme oxygenase 1 levels
Osteoclast-associated immunoglobulin-like receptor levels
Heat shock 27 kDa protein levels
Alpha-L-iduronidase levels
Low affinity immunoglobulin gamma Fc region receptor II-b levels
Pro-interleukin-16 levels
Interleukin-17D levels
Platelet endothelial cell adhesion molecule levels
Peptidoglycan recognition protein 1 levels
Elafin levels
Perlecan levels
Paraoxonase activity
Myeloblastin levels
Pulmonary surfactant-associated protein D levels
Retinoic acid receptor responder protein 2 levels
Resistin levels
Secretoglobin family 3A member 2 levels
E-selectin levels
P-selectin levels
Tyrosine-protein phosphatase non-receptor type substrate 1 levels
Spondin-1 levels
ST2 protein levels
Metalloproteinase inhibitor 4 levels
Trem-like transcript 2 protein levels
Tumor necrosis factor receptor 1 levels
Tumor necrosis factor receptor 2 levels
Tumor necrosis factor receptor superfamily member 10C levels
Tumor necrosis factor receptor superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 13B levels
Tissue-type plasminogen activator levels
Transferrin receptor protein 1 levels
Insulin-like growth factor-binding protein 7 levels
Interleukin-17 receptor A levels
Interleukin-18-binding protein levels
Interleukin-1 receptor type 1 levels
Interleukin-1 receptor type 2 levels
Interleukin-2 receptor subunit alpha levels
Interleukin-6 receptor subunit alpha levels
Integrin beta-2 levels
Junctional adhesion molecule A levels
Kallikrein-6 levels
Low-density lipoprotein receptor levels
Lymphotoxin-beta receptor levels
Myoglobin levels
Matrix extracellular phosphoglycoprotein levels
Matrix metalloproteinase-2 levels
Matrix metalloproteinase-3 levels
Matrix metalloproteinase-9 levels
Myeloperoxidase levels
Neurogenic locus notch homolog protein 3 levels
Osteoprotegerin levels
Osteopontin levels
Plasminogen activator inhibitor-1 (PAI-1) levels
Proprotein convertase subtilisin/kexin type 9 levels
Platelet-derived growth factor subunit A levels
Scavenger receptor cysteine-rich type 1 protein M130 levels
Complement component C1q receptor levels
Cadherin-5 levels
Chitinase-3-like protein 1 levels
Chitotriosidase-1 levels
Contactin-1 levels
Collagen alpha-1 (I) chain levels
Carboxypeptidase A1 levels
Carboxypeptidase B levels
Cystatin-B levels
Cathepsin D levels
Cathepsin Z levels
C-X-C motif chemokine 16 levels
Protein delta homolog 1 levels
Epidermal growth factor levels
epithelial cell adhesion molecule levels
Ephrin type-B receptor 4 levels
"Fatty acid-binding protein, adipocyte levels"
Tumor necrosis factor receptor superfamily member 6 levels
Galectin-3 levels
Galectin-4 levels
Granulins levels
Intercellular adhesion molecule 2 levels
Insulin-like growth factor-binding protein 1 levels
Insulin-like growth factor-binding protein 2 levels
Interleukin-1 receptor-like 2 levels
Interleukin-27 levels
Interleukin-4 receptor subunit alpha levels
Kidney Injury Molecule levels
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-120 minutes)
Glucagon levels in response to oral glucose tolerance test (30 minutes)
COVID-19 (critical illness vs population)
Testosterone levels x fluid intelligence interaction
Testosterone levels x alcohol consumption (drinks per week) interaction
Testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x alcohol consumption (drinks per week) interaction
Bioavailable testosterone levels x fluid intelligence interaction
Estradiol levels x smoking behaviour (cigarettes smoked per day) interaction
Estradiol levels x alcohol consumption (drinks per week) interaction
Estradiol levels x fluid intelligence interaction
Sex hormone-binding globulin levels x smoking behaviour (cigarettes smoked per day) interaction
Sex hormone-binding globulin levels x alcohol consumption (drinks per week) interaction
Sex hormone-binding globulin levels x fluid intelligence interaction
Childhood body mass index
Nonunion in individuals with fractures
Diabetic retinopathy (all NPDR and PDR)
Proliferative diabetic retinopathy (vs NPDR and no DR)
Diabetic retinopathy (moderate NPDR and PDR)
Proliferative diabetic retinopathy (vs no DR)
Panic disorder
Hospital contact for infections
Brain age (difference between predicted and chronological age)
Circulating leptin levels in high cardiovascular risk
Circulating leptin levels x sex interaction in high cardiovascular risk
B-cell acute lymphoblastic leukaemia
B-cell acute lymphoblastic leukaemia (high-hyperdiploidy)
B-cell acute lymphoblastic leukaemia (ETV6-RUNX1 positive)
Protein level change in low calorie diet obesity intervention
Protein levels in obesity
Head and neck squamous cell carcinoma
Youthful appearance (self-reported)
Type 2 diabetes (adjusted for BMI)
Urinary incontinence
Stress urinary incontinence
Urgency urinary incontinence
Stress urinary incontinence and urgency urinary incontinence
Fecal incontinence
Impaired insulin sensitivity in response to n-3 PUFA supplementation
Trunk fat mass adjusted for trunk lean mass
Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass
HDL cholesterol levels x short total sleep time interaction (2df test)
LDL cholesterol levels x long total sleep time interaction (2df test)
LDL cholesterol levels x short total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (2df test)
Triglyceride levels x short total sleep time interaction (2df test)
HDL cholesterol levels x long total sleep time interaction (1df test)
Triglyceride levels x short total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (1df test)
LDL cholesterol levels x long total sleep time interaction (1df test)
LDL cholesterol levels x short total sleep time interaction (1df test)
HDL cholesterol levels x long total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (1df test)
Retinal detachment
Retinal detachment or retinal break
Retinal detachment with retinal break
High myopia
Cataracts (operation)
Bone mineral density (hip)
Hip bone size
Bone mineral density (hip) and hip bone size
Occipital lobe volume
Parietal lobe volume
Temporal lobe volume
Frontal lobe volume
Birth weight (MTAG)
Birth length (MTAG)
Infant head circumference (MTAG)
Facial morphology
Colorectal cancer x BMI interaction (2df)
Spherical equivalent
Leptin levels
Spondin-2 levels
Macrophage receptor MARCO levels
Tissue factor levels
Matrix metalloproteinase-12 levels
Thrombospondin-2 levels
NF-kappa-B essential modulator levels
Angiopoietin-1 receptor levels
Proteinase-activated receptor 1 levels
Tumor necrosis factor receptor superfamily member 10A levels
Platelet-derived growth factor subunit B levels
Tumor necrosis factor receptor superfamily member 13B levels
Placenta growth factor levels
vascular endothelial growth factor D levels
Prolargin levels
Serine protease 27 levels
Prostasin levels
CD166 antigen levels
Pentraxin-related protein PTX3 levels
Tyrosine-protein kinase receptor UFO levels
Renin levels
Bleomycin hydrolase levels
Serpin A12 levels
C-C motif chemokine 15 levels
"Superoxide dismutase [Mn],mitochondrial levels"
C-C motif chemokine 24 levels
Sortilin levels
Lipoprotein lipase levels
Serine/threonine-protein kinase 4 levels
Tyrosine-protein kinase Mer levels
Protein-glutamine gamma-glutamyltransferase 2 levels
Matrix metalloproteinase-7 levels
Thrombopoietin levels
Pappalysin-1 levels
Thrombomodulin levels
Poly [ADP-ribose] polymerase 1 levels
Tumor necrosis factor receptor superfamily member 11A levels
Programmed cell death 1 ligand 2 levels
TNF-related apoptosis-inducing ligand receptor 2 levels
Polymeric immunoglobulin receptor levels
V-set and immunoglobulin domain-containing protein 2 levels
XCL1 levels
P-selectin glycoprotein ligand 1 levels
Aminopeptidase N levels
Receptor for advanced glycosylation end products levels
Azurocidin levels
Caspase-3 levels
SLAM family member 7 levels
C-C motif chemokine 16 levels
Disease free survival in colon cancer
Survival in colon cancer
Coronary artery disease in diabetes
Penicillin allergy
Ewing sarcoma
Café-au-lait macule number in neurofibromatosis type1
Dietary macronutrient intake
Depressed affect
Worry
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase (TPOAb) levels)
Anhedonia
Coffee consumption
Green tea consumption
Milk consumption
Yoghurt consumption
Cheese consumption
Natto consumption
Tofu consumption
Fish intake frequency
Small whole fish consumption
Vegetable consumption
Meat consumption
Blood urea nitrogen levels
Myopia (age of diagnosis)
Spherical equivalent or myopia (age of diagnosis)
Mucinous adenocarcinoma in colorectal cancer
Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction (parent of origin effect)
Osteoarthritis of the hand
Serum alpha-fetoprotein levels
Serum carcinoembryonic antigen levels
Serum cancer antigen 15.3 levels
Serum cancer antigen 19.9 levels
Serum cancer antigen 125 levels
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)
Opioid dependence in opioid exposure
Opioid exposure
Neuromyelitis optica
Neuromyelitis optica (AQP4-IgG-positive)
Neuromyelitis optica (AQP4-IgG-negative)
Central corneal thickness
Executive function in ADHD
Optic cup area
Optic disc area
Vertical cup-disc ratio
Optic nerve head parameters (multi-trait analysis)
Intraocular pressure and central corneal thickness (multi-trait analysis)
Optic disc size
Cognitive decline (age-related)
Dysmenorrheic pain severity
Menstruation quality of life impact (dysmenorrhea)
Pain medicine use during menstruation
Menstruation quality of life impact (fever)
Heavy vaginal discharge
Menstruation quality of life impact (acne)
Menstruation quality of life impact (aggressiveness)
Menstruation quality of life impact (increased appetite)
Menstruation quality of life impact (bowel movement)
Menstruation quality of life impact (depression)
Menstruation quality of life impact (edema)
Menstruation quality of life impact (headache)
Menstruation quality of life impact (joint pain)
Menstruation quality of life impact (loss of concentration)
Menstruation quality of life impact (nervousness)
Menstruation quality of life impact (pressure in breast)
Menstruation quality of life impact (sleepiness)
Menstruation quality of life impact (stiff neck)
Vaginal discharge (itching)
Vaginal discharge (metrorrhagia)
Vaginal discharge (smell)
Breast size
End stage renal disease x APOL1 genotype interaction
End stage renal disease in APOL1 risk genotype-negative individuals
End stage renal disease in APOL1 risk genotype-positive individuals
End-stage renal disease
Bone mineral density (total hip)
High bone mineral density
Brain region volumes
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Elevated fasting plasma glucose
Alzheimer's disease (onset at age over 80)
Alzheimer's disease (onset between ages 58 and 79)
Type 1 diabetes in high risk HLA genotype individuals (time to event)
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
Freckles
Double-edged eyelids
Thick vs thin eyebrows
Straight vs curly hair
Excessive hairiness
Excessive sweating
Age spots
Childhood onset systemic lupus erythematosus
Urinary calcium excretion
Urinary magnesium excretion
Urinary uric acid excretion
Urinary volume
Meningioma
Lactose tolerance test
Inflammatory bowel disease
Chronic pain or major depressive disorder (pleiotropy)
Lung cancer x radon exposure interaction (1df)
Systolic blood pressure night-to-day ratio in hypertension
Diastolic blood pressure night-to-day ratio in hypertension
Cannabis use (age at onset)
Self-reported risk-taking behaviour
Schizophrenia or schizoaffective disorder
Schizophrenia (MTAG)
Osteoporosis-related phenotypes (MTAG)
Rosacea symptom severity
Low tan response
Non-small cell lung cancer in heavy smokers
"Obstructive sleep apnea trait (apnea hypopnea index, change over time)"
Behavioural changes in frontotemporal lobe dementia
Frontotemporal dementia (age at onset)
Frontotemporal dementia with GRN mutation
Frontotemporal dementia with GRN mutation (age at onset)
Frontotemporal dementia
Memory dysfunction in frontotemporal lobe dementia
Language impairment in frontotemporal lobe dementia
Parkinsonism in frontotemporal lobe dementia
Opioid dependence x sex interaction
Anti-chlamydia trachomatis IgG seropositivity
Uterine fibroids
Uterine fibroids (MTAG)
Endometriosis (MTAG)
Ovarian cancer
Ovarian cancer (MTAG)
Endometrial cancer
Endometrial cancer (MTAG)
Gynecologic disease
Cervical cancer
Cervical cancer (MTAG)
Gynecologic disease (multivariate analysis)
Exacerbations requiring hospitalisation in asthma
Cerebrospinal fluid α-synuclein levels
Autoimmune thyroid disease
Attention deficit hyperactivity disorder (inattention symptoms)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
Response to antiepileptic mood-stabilizing treatment in bipolar disorder
4E-BP1 levels
Adenosine Deaminase levels
Axin-1 levels
Caspase 8 levels
CCL11 levels
CCL19 levels
CCL20 levels
CCL23 levels
CCL25 levels
CCL28 levels
CCL3 levels
CCL4 levels
CD244 levels
CD40 levels
CD5 levels
CD6 levels
CDCP1 levels
Colony stimulating factor levels
Cystatin D levels
CX3CL1 levels
CXCL1 levels
CXCL10 levels
CXCL11 levels
CXCL5 levels
Protein quantitative trait loci
Cardiovascular death or myocardial infarction in response to clopidogrel treatment
"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment"
Stent thrombosis in response to clopidogrel treatment
Platelet reactivity in response to clopidogrel treatment
Essential hypertension (time to event)
Abdominal hernia (time to event)
Hyperlipidemia (time to event)
Osteoarthrosis (time to event)
Cardiac dysrhythmias (time to event)
Asthma (time to event)
Cataract (time to event)
Coronary atherosclerosis (time to event)
Type 2 diabetes (time to event)
Parkinson's disease (time to event)
Alzheimer's disease (time to event)
Schizophrenia (time to event)
Chronotype (sMEQ score)
Evening vs. morning chronotype (sMEQ score)
Evening vs. morning chronotype (self-assessed)
Multiple myeloma
Monoclonal gammopathy of undetermined significance
"CV-A6-associated hand, foot, and mouth disease (severe vs mild)"
Rate of cognitive decline in Alzheimer's disease
Acute anterior uveitis in ankylosing spondylitis
Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis)
L-selectin levels
Arterial stiffness (carotid-femoral pulse wave velocity)
Arterial stiffness (brachial-femoral pulse wave velocity)
Arterial stiffness (brachial-ankle pulse wave velocity)
Total carotid plaque area (excess vs minimal atherosclerosis)
Persistent chemotherapy-induced alopecia in breast cancer
Myocardial fractal dimension (slice 1)
Myocardial fractal dimension (slice 2)
Myocardial fractal dimension (slice 3)
Myocardial fractal dimension (slice 4)
Myocardial fractal dimension (slice 5)
Myocardial fractal dimension (slice 6)
Myocardial fractal dimension (slice 7)
Myocardial fractal dimension (slice 8)
Myocardial fractal dimension (slice 9)
Myocardial fractal dimension (slices 1-9)
Vaginal microbiome composition (L. iners)
Vaginal microbiome composition (G. vaginalis)
Vaginal microbiome composition (Shannon diversity index)
Vaginal microbiome composition (community state type)
Vaginal microbiome composition (L. crispatus)
Combined resilience (covariance of educational attainment with residual cognitive resilience)
Residual cognitive resilience
Early-onset ischemic stroke
Adverse response to chemoterapy (fluoropyrimidines)
Hepatic steatosis in non-alcoholic fatty liver disease
Liver fibrosis in non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis activity score in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease
Nonalcoholic steatohepatitis
Severe liver fibrosis and non-alcoholic fatty liver disease
Pancreatic beta-cell glucose sensitivity
Serum C-reactive protein concentration
Serum C-reactive protein concentration in non-obese individuals
Serum C-reactive protein concentration in obesity
Serum C-reactive protein concentration in inactive individuals
Serum C-reactive protein concentration in low fat diet
Serum C-reactive protein concentration in high fat diet
Serum C-reactive protein concentration in visceral obesity (waist-hip ratio)
Serum C-reactive protein concentration in visceral obesity (waist circumference)
Serum interleukin-6 concentration
Serum interleukin-6 concentration in non-visceral-obese individuals
Serum interleukin-6 concentration in high fat diet
Serum interleukin-6 concentration in active individuals
Shoulder impingement syndrome
Postoperative nausea and vomiting
circulating leptin levels
circulating leptin levels adjusted for BMI
Neuroblastoma (pediatric)
Multiple severe cisplatin-induced neurotixicitiies in testicular cancer survivors
Chronic back pain
Concussion
Leprosy
Theta EEG coherence
Restless legs syndrome in migraine without aura
Restless legs syndrome in migraine with aura
Restless legs syndrome in migraine
Invasive breast cancer
"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"
Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months)
Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)
Tafenoquine efficacy in P. vivax malaria (time to recurrence up to 6 months)
Lean mass index
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)
Anemia in mycophenolic acid treated kidney transplant patients (time to event)
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)
Meconium ileus in cystic fibrosis
Modic changes
Household income
Cortical surface area
Left ventricular mass x antihypertensive treatment interaction
Relative wall thickness x antihypertensive treatment interaction
Arsenic metabolism
Thyroid volume in Hashimoto’s thyroiditis
Tourette syndrome
Bladder cancer
Adverse response to inhaled corticosteroid treatment x age interaction in asthma
Calcific aortic valve stenosis
Erosive esophagitis
Creativity
Weight gain in amisulpride-treated first-episode psychosis
Alzheimer's disease (late onset)
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function
Insomnia symptoms (never/rarely vs. sometimes/usually)
Insomnia symptoms (never/rarely vs. usually)
Anthracycline-induced cardiotoxicity
Pancreatic cancer
Chronic hepatitis B infection
World class endurance athleticism
Alzheimer's disease in depression
Cognitive function in depression
Cognitive impairment in depression
Cognitive decline in depression
Morningness
Matrix metalloproteinase levels
Matrix metalloproteinase-10 levels
Neurotrophin-3 levels
Oncostatin-M levels
PD-L1 levels
Sirtuin-2 levels
SLAMF1 levels
Sulfotrasferase 1A1 levels
STAM binding protein levels
Transforming growth factor-alpha levels
Tumor necrosis factor receptor superfamily member 9 levels
Tumor necrosis factor ligand superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 10 levels
Tumor necrosis factor ligand superfamily member 11 levels
Tumor necrosis factor ligand superfamily member 12 levels
Vascular endothelial growth factor A levels
CXCL6 levels
CXCL9 levels
DNER levels
EN-RAGE levels
Fibroblast growth factor 19 levels
Fibroblast growth factor 5 levels
Flt3L levels
Interleukin-10 receptor B levels
Interleukin-12 subunit B levels
interleukin 15 receptor subunit alpha levels
interleukin-18 receptor 1 levels
Transforming growth factor-beta levels
Leukemia inhibitory factor receptor levels
Monocyte chemoattractant protein-2 levels
Monocyte chemoattractant protein-4 levels
Receptive language ability
Parent of origin effect on receptive language ability (paternal)
Parent of origin effect on receptive language ability (maternal)
"Gut microbiota (bacterial taxa, hurdle binary method)"
"Gut microbiota (bacterial taxa, rank normal transformation method)"
Nontraumatic osteonecrosis of the femoral head
Drug-induced liver injury
Severe COVID-19 infection with respiratory failure (analysis I)
Severe COVID-19 infection with respiratory failure (analysis II)
Thrombin-induced platelet aggregation
Peginterferon alfa-2a treatment response in chronic hepatitis B infection
Migraine and/or diastolic blood pressure
Migraine and/or systolic blood pressure
Migraine and/or pulse pressure
Migraine with aura and/or diastolic blood pressure
Migraine with aura and/or systolic blood pressure
Migraine with aura and/or pulse pressure
Migraine without aura and/or diastolic blood pressure
Migraine without aura and/or systolic blood pressure
Migraine without aura and/or pulse pressure
Antibody-deficiency-associated primary immunodeficiency
Lung cancer (survival time) in never smokers
Lung adenocarcinoma (survival time) in never smokers
Fasting plasma glucose
Cognitive function
Hip bone mineral content accrual during adolescent growth spurt
Peak hip bone mineral content
Suicide attempts
Deliberate self-harm
Tau burden
Preeclampsia (fetal genotype effect)
Preeclampsia (maternal genotype effect)
2-hydroxyisobutyrate levels
3-aminoisobutyrate levels
3-hydroxybutyrate + 3-aminoisobutyrate levels
3-hydroxyisobutyrate levels
3-hydroxyisovalerate levels
3-Indoxylsulfate levels
4-deoxyerythronic acid levels
4-deoxythreonic acid levels
5-oxoproline levels
Acetate levels
Acetone levels
Alanine levels
Carnitine levels
Citrate levels
Creatine levels
Dimethylamine levels
Formate levels
Glucose levels
Glutamine levels
Glycine levels
Hippurate levels
Isoleucine levels
Lactate levels
Leucine levels
Lysine levels
N-acetyl neuraminic acid levels
N-methyl-2-pyridone-5-carboxamide levels
N-methylnicotinic acid levels
N-methylpicolinic acid levels
N1-methyl-nicotinamide levels
P-cresol sulfate levels
P-hydroxyphenylacetate levels
Pantothenic acid levels
Proline betaine levels
Scyllo-inositol levels
Succinate levels
Sucrose levels
Taurine levels
Trimethylamine levels
Trimethylamine oxide levels
Tyrosine levels
Valine levels
Amyotrophic lateral sclerosis
Diabetic neuropathy in type 2 diabetes
Type 2 diabetes nephropathy
Macrovascular complications in type 2 diabetes
Ophthalmic complications in type 2 diabetes
Thrombosis in response to liver transplant
Keratinocyte cancer (MTAG)
"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)"
Obesity (extreme)
Normal body mass index vs. thin
Cardiovascular disease in systemic lupus erythematosus
Caffeine consumption from coffee
Caffeine consumption from tea
Caffeine consumption from coffee or tea
Obese vs. thin
Triglyceride levels in HIV infection
LDL cholesterol levels in HIV infection
HDL cholesterol levels in HIV infection
Parental lifespan
First year height change in growth hormone-treated short stature
Heel bone mineral density
Fractures
Facial morphology traits (59 NSCL/P endophenotypic segments)
Leg fat mass (lean adjusted)
Leg lean mass (fat adjusted)
Leg fat mass and leg lean mass (pleiotropy)
Systemic mastocytosis
Cutaneous mastocytosis
Cutaneous mastocytosis (adult)
Mastocytosis
Cutaneous mastocytosis (childhood)
Tumor necrosis factor levels
Percent liver fat
Liver fat content (MRI proton density fat fraction measure)
Liver fibrosis and steatohepatitis severity (MRI cT1 measure)
Major depressive disorder (lifetime)
Major depressive disorder (lifetime with recurrence)
Help-seeking from a GP
Help-seeking from a psychiatrist
Major depressive disorder symptoms (low mood or anhedonia)
Help-seeking from a GP (without major depressive disorder symptoms)
Depression or depression symptoms
Septic shock (28-day mortality)
Septic shock (90-day mortality)
Septic shock resolution
Septic shock
FEV1/FVC ratio x pack-years of smoking interaction (2df test)
Behcet's disease
Alcohol use disorder
Problematic alcohol use (MTAG)
Alcohol consumption (drinks per week) (MTAG)
Problematic alcohol use
Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism
Atopic dermatitis
Leukoderma in response to rhododendrol
Autoimmune traits
Mental disorder
Autoimmune disease (without mental disorder)
Mental disorder (without autoimmune disease)
Autoimmune disease and mental disorder
Deep white matter hyperintensities
Periventricular white matter hyperintensities
Serum uric acid levels
Suicide attempts in major depressive disorder
White matter microstructure (mean diusivities)
White matter microstructure (axial diusivities)
White matter microstructure (radial diusivities)
White matter microstructure (mode of anisotropy)
White matter microstructure (fractional anisotropy)
Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer
Self-harm ideation
Gestational insulin sensitivity
Clozapine concentration in schizophrenia
N-desmethylclozapine concentration in schizophrenia
Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia
Dietary fat liking
"Allergic disease (asthma, hay fever and/or eczema) (age of onset)"
"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)"
Osteoporosis
Gastric cancer
Infantile hypertrophic pyloric stenosis
Parent of origin effect on language impairment (paternal)
Parent of origin effect on language impairment (maternal)
Political ideology
Coronary artery disease-related phenotypes
Resting heart rate
Ossification of the posterior longitudinal ligament of the spine
Recombination measurement
General cognitive ability
Basal cell carcinoma
Irritable bowel syndrome
Cocaine dependence
Recombination measurement (females)
Recombination measurement (males)
Skin youthfulness
Diabetic retinopathy in type 2 diabetes
Skin fluorescence
Crohn's disease-related phenotypes
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection
"Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)"
Androgen levels
Carotid plaque burden (smoking interaction)
Paclitaxel-induced neuropathy
Serum lipase activity
High serum lipase activity
Memory performance
Lipopolysaccharide induced cytokine levels
Asthma and hay fever
Obesity
Pain
AIDS progression
Fractures (vertebral)
Rheumatoid factor
Anti-citrullinated peptide antibody
Blood pressure variability
Sleep time
Sleep quality
Sleep depth
Sleep latency
Melanoma
Response to radiotherapy in prostate cancer (toxicity)
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)
Percent mammographic density
Beta-2 microglubulin plasma levels
Stroke (ischemic)
Mammographic density (dense area)
Mammographic density (non-dense area)
Angioedema in response to angiotensin-converting enzyme inhibitor
Confectionary intake
Age-related macular degeneration
Carotid intima media thickness
Bladder cancer (smoking interaction)
Thoracic aortic aneurysms and dissections
Cytomegalovirus antibody response
Red blood cell traits
Chronic hepatitis C infection
Protein biomarker
Serum vitamin D-binding protein levels
Febrile seizures
Febrile seizures (MMR vaccine-unrelated)
Exudative age-related macular degeneration
Acoustic startle blink response
Diffuse large B cell lymphoma
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Sickle cell anemia (haemolysis)
Birdshot chorioretinopathy
Aggressive periodontitis (sex interaction)
Myopia (pathological)
Blood pressure response to hydrochlorothiazide in hypertension
Facial pigmentation
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia
Milk allergy
Egg allergy
Plasma plasminogen activator levels
C-reactive protein
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement
Periodontitis
Oligoclonal band status in multiple sclerosis
Immunoglobulin G index levels in multiple sclerosis
Subcortical brain region volumes
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)
Takayasu arteritis
Chronic bronchitis and chronic obstructive pulmonary disease
Chronic bronchitis in chronic obstructive pulmonary disease
Trans fatty acid levels
Platinum-induced myelosuppression in non-small cell lung cancer
C-reactive protein levels in ischemic stroke
Thrombomodulin levels in ischemic stroke
Creatinine levels in ischemic stroke
Thrombin-antithrombin complex levels in ischemic stroke
Fibrinogen levels in ischemic stroke
Prothrombin fragments F1+2 levels in ischemic stroke
Eating disorder in bipolar disorder
Bipolar disorder and eating disorder
Setpoint viral load in HIV-1 infection
Response to lithium treatment in bipolar disorder (dichotomous phenotype)
Response to lithium treatment in bipolar disorder (continuous phenotype)
Multiple system atrophy
Parental longevity (father's age at death)
Parental longevity (mother's age at death)
Parental longevity (combined parental age at death)
Parental extreme longevity (95 years and older)
Liver fibrosis severity in HIV/hepatitis C co-infection
Collagenous colitis
Pathological gambling
Morning vs. evening chronotype
Sleep duration (oversleepers vs undersleepers)
Sleep duration (oversleepers)
Sleep duration (undersleepers)
Aggressive prostate cancer
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia
Celiac disease and Rheumatoid arthritis
Mathematical ability
Late-onset myasthenia gravis
Response to Pazopanib in cancer (hepatotoxicity)
Survival in colorectal cancer
Survival in colorectal cancer (non-distant metastatic)
Survival in colorectal cancer (distant metastatic)
Body mass index variance
Anti-thyroid drug induced agranulocytosis
Non-chemotherapy drug induced agranulocytosis
Cognitive impairment (brain beta-amyloid deposition interaction)
"Parkinson's disease (non-familial, age at onset)"
"Parkinson's disease (familial, age at onset)"
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)
Schizophrenia
Clinical laboratory measurements
Cancer (pleiotropy)
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder
Bipolar disorder or attention deficit hyperactivity disorder
Ischemic stroke (cardioembolic)
Ischemic stroke (non-cardioembolic)
Gastric adenocarcinoma (histologically verified)
Arterial stiffness (pulse-wave velocity)
Thionamide-induced agranulocytosis in Graves' disease
Ear protrusion
Tragus size
Antitragus size
Crus helix expression
Superior crus of antihelix expression
Darwin's tubercle
Ear morphology
Lobe size
Lobe attachment
Helix rolling
Folding of antihelix
Cardia gastric cancer
Non-cardia gastric cancer
Noise-induced hearing loss
Rheumatoid factor seropositivity in rheumatoid arthritis
Sense of smell
Major depressive disorder (stressful life events interaction)
Thyroid-associated orbitopathy in graves' disease
Migraine
Migraine without aura
Migraine with aura
middle facial morphology traits (ordinal measurement)
lower facial morphology traits (ordinal measurement)
middle facial morphology traits (quantitative measurement)
lower facial morphology traits (quantitative measurement)
facial morphology traits (multivariate analysis)
upper facial morphology traits (ordinal measurement)
Severity of facial solar lentigines
Metabolite levels (lipid measures)
Metabolite levels (small molecules and protein measures)
Metabolite levels (lipoprotein measures)
Endometrial endometrioid carcinoma
Pneumococcal bacteremia
Bacteremia
Gestational age at birth in labor-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)
Gestational age at birth in labor-initiated deliveries (maternal effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)
Gestational age at birth (child effect)
Bone mineral density (Ward's triangle area)
Number of children ever born
Age at first birth
Macular telangiectasia type 2
Midgestational circulating levels of organochlorine pesticides
Midgestational circulating levels of PCBs (fetal genetic effect)
Midgestational circulating levels of PBDEs
Midgestational circulating levels of PBDEs (fetal genetic effect)
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)
Midgestational circulating levels of PCBs
Maximal oxygen uptake response
knee peak torque response
Antipsychotic drug-induced weight gain in schizophrenia
Loneliness (multivariate analysis)
Loneliness
Loneliness (linear analysis)
Excessive daytime sleepiness
Sleep traits (multi-trait analysis)
Response to dendritic cell-based immunotherapy in HIV infection
Thiopurine S-methyltransferase activity
"Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)"
"Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)"
"Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)"
"Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)"
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)
Monocyte-lymphocyte ratio
Presence of antiphospholipid antibodies
Skin fluorescence in type 1 diabetes
Antithyroid drug-induced agranulocytosis
Nonsyndromic cleft lip with cleft palate
Extraversion
Bone mineral density (spine) and age at menarche
Bone mineral density (hip) and age at menarche
Obstructive sleep apnea (average oxygen saturation during sleep)
Obstructive sleep apnea trait (average respiratory event duration)
Glucocorticoid-induced osteonecrosis (time dependent analysis)
Glucocorticoid-induced osteonecrosis (time independent analysis)
Glucocorticoid-induced osteonecrosis
Survival in breast cancer (estrogen-receptor negative)
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Acute mountain sickness
Endophenotypes for schizophrenia in healthy individuals
Urinary albumin-to-creatinine ratio in diabetes
Urinary albumin-to-creatinine ratio in non-diabetics
Microalbuminuria
Urinary albumin-to-creatinine ratio
Multiple myeloma and monoclonal gammopathy
Paclitaxel-induced cytotoxicity
Sporadic pituitary adenoma
Epilepsy and lamotrigine-induced maculopapular eruptions
Epilepsy
Multiple myeloma (survival)
Postoperative atrial fibrillation in coronary artery bypass grafting surgery
Staphylococcus aureus infection
Skin and soft tissue Staphylococcus aureus infection
White matter lesion progression
White matter lesion progression (adjusted for white matter lesion burden at baseline)
Antipsychotic drug-induced weight gain
Antipsychotic drug-induced weight gain (time interaction)
Plasma lactate levels
Acylcarnitine levels
Amino acid levels
Glycerophospholipid levels
Sphingolipid levels
Hexose levels
Skin colour saturation
Perceived skin darkness
Skin sensitivity to sun
Response to zileuton treatment in asthma (FEV1 change interaction)
Peak creatinine levels in vancomycin therapy
Vancomycin trough in vancomycin therapy
Renal elimination rate in vancomycin therapy
Hypersomnia during a major depressive episode in bipolar disorder
Blond vs non-blond hair color
Brown vs. non-brown hair color
Light vs. dark hair color
Red vs non-red hair color
Black vs. non-black hair color
Cough in response to angiotensin-converting enzyme inhibitor drugs
Warfarin maintenance dose
Postprandial triglyceride response to high fat diet meal
Mitral valve prolapse
Platelet thrombus formation
Postburn hypertrophic scarring severity
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression
Manic episodes in bipolar disorder
Depressive episodes in bipolar disorder
Depressive and manic episodes in bipolar disorder
Serum lycopene concentrations
Low bone mineral density (spine)
Low bone mineral density (hip)
Bone mineral accretion in asthma (oral corticosteroid dose interaction)
Classic bladder exstrophy
Lapatinib-induced hepatotoxicity
Sex hormone levels
Platelet aggregation
Adolescent idiopathic scoliosis
Serum alpha1-antitrypsin levels
Ultraviolet-induced skin pigmentation (minimal erythema dose)
Anthracycline-induced cardiotoxicity in childhood cancer
Parkinson's disease in GBA mutation carriers (age at onset)
Lung cancer (asbestos exposure interaction)
Pediatric autoimmune diseases
Post-bronchodilator lung function in asthma (FEV1)
Post-bronchodilator lung function in asthma (FEV1/FVC)
Staphylococcus aureus nasal carriage (persistent)
Staphylococcus aureus nasal carriage (intermittent)
Myositis
Influenza A (H1N1) severity
Influenza A (H1N1) infection
Mild influenza (H1N1) infection
Severe influenza A (H1N1) infection
Proteinuria in chronic kidney disease
Proteinuria and chronic kidney disease
Glomerular filtration rate in chronic kidney disease
Colorectal or endometrial cancer
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)
Longitudinal change in brain amyloid plaque burden
Asparaginase hypersensitivity in acute lymphoblastic leukemia
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis
3-hydroxypropylmercapturic acid levels in smokers
3-hydroxy-1-methylpropylmercapturic acid levels in smokers
Cannabis use (initiation)
Yu-Zhi constitution type in type 2 diabetes
HIV-1 viral setpoint
Response to simvastatin treatment (PCSK9 protein level change)
Sight-threatening diabetic retinopathy in type 2 diabetes
Hearing function (high tone)
Hearing function (0.25 kHz)
Hearing function (0.5 kHz)
Hearing function (1 kHz)
Hearing function (2 kHz)
Hearing function (4 kHz)
Hearing function (8 kHz)
Hearing function (low tone)
Hearing function (medium tone)
MGMT methylation in smokers
Soluble interleukin-2 receptor subunit alpha
Rotator cuff tears
Diabetic kidney disease
Adiponectin levels (BMI-adjusted)
Pediatric areal bone mineral density (radius)
Pediatric bone mineral content (radius)
Response to stavudine in HIV (lipoatrophy)
Percentage gas trapping
Airway imaging phenotypes
Emphysema imaging phenotypes
Perioperative myocardial infarction in coronary artery bypass surgery
Pyoderma gangrenosum in inflammatory bowel disease
Erythema nodosum in inflammatory bowel disease
Blood pressure
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
Atrioventricular septal defects in Down syndrome
Trichloroethylene-induced hypersensitivity syndrome
Asperger syndrome
Cryptorchidism
Attention function in attention deficit hyperactive disorder
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)
Urinary metabolites
Lung disease severity in cystic fibrosis
Coronary artery aneurysm in Kawasaki disease
Cingulate cortical amyloid beta load
Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Juvenile osteochondritis dissecans
Drug-induced liver injury (terbinafine)
Drug-induced hepatocellular liver injury
Drug-induced liver injury (statins)
Drug-induced cholestatic/mixed liver injury
Drug-induced liver injury (nitrofurantoin)
Drug-induced liver injury (diclofenac)
Drug-induced liver injury (anti-tuberculosis drugs)
Drug-induced liver injury (fluoroquinolones)
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)
Whole body bone mineral density and alcohol drinking
Hip bone mineral density and alcohol drinking
Spine bone mineral density and alcohol drinking
Gut microbiota (bacterial taxa)
QT interval (tricyclic/tetracyclic antidepressant use interaction)
RR interval (tricyclic/tetracyclic antidepressant use interaction)
Clopidogrel active metabolite levels
Response to clopidogrel therapy
Glomerular load of uric acid
Uric acid clearance
Fractional excretion of uric acid
Creatinine clearance
Urinary uric acid to urinary creatinine ratio
Sepsis in extremely premature infants
Osteoarthritis (with total hip replacement)
Venous thromboembolism adjusted for sickle cell variant rs77121243-T
Rectal cancer
Colon cancer
Response to paliperidone in schizophrenia (positive Marder score)
Response to paliperidone in schizophrenia (negative Marder score)
Response to paliperidone in schizophrenia (PANSS score)
Response to paliperidone in schizophrenia (Multivariate)
Response to paliperidone in schizophrenia (CGI-S score)
Prostate-specific antigen levels
Prostate-specific antigen levels (conditioned on lead SNPs)
Exhaled nitric oxide output
Exhaled nitric oxide levels
Systolic blood pressure (long-term average)
Diastolic blood pressure (long-term average)
Pulse pressure (long-term average)
Mean arterial pressure (long-term average)
Immune response to measles vaccine (measles-specific neutralising antibody titre)
Immune response to measles vaccine (measles-induced IFN gamma)
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
Gut microbiota (beta diversity)
Palmitoleic acid (16:1n-7) levels
Vaccenic acid (18:1n-7) levels
Oleic acid (18:1n-9) levels
Gondoic acid (20:1n-9) levels
Erucic acid (22:1n-9) levels
Nervonic acid (24:1n-9) levels
Gut microbiota (functional units)
Adiponectin levels in pregnancy
Bortezomib-induced peripheral neuropathy in multiple myeloma
Carotid plaque burden
Body fat mass
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)"
Phlegm
Dyspnea
Cough
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder
Educational attainment (years of education)
Educational attainment (college completion)
Large artery stroke
Crohn's disease
Resistance to antihypertensive treatment in hypertension
Gallbladder cancer
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3
Antineutrophil cytoplasmic antibody-associated vasculitis
Depressive symptoms (stressful life events interaction)
"Urinary 1,3-butadiene metabolite levels in smokers"
Pulmonary artery enlargement and chronic obstructive pulmonary disease
Pulmonary artery enlargement in chronic obstructive pulmonary disease
Longevity (90 years and older)
Longevity (85 years and older)
Response to thiazide diuretic treatment (hypokalemia)
Nicotine use
Illicit drug use
Non-substance related behavioral disinhibition
Behavioural disinhibition (generation interaction)
Coronary heart disease in familial hypercholesterolemia
Smoking quantity
Smoking initiation
Smoking cessation
Autism
Glycemic traits (pregnancy)
Acute lymphoblastic leukemia (childhood)
Medication adherence in chronic diseases
Serum thyroid-stimulating hormone levels
Episodic memory
Chronic obstructive pulmonary disease (moderate to severe)
Chronic obstructive pulmonary disease (severe)
Blood pressure (anthropometric measures interaction)
Acne (severe)
Age-related hearing impairment
Age-related hearing impairment (SNP x SNP interaction)
Eosinophilic esophagitis
IgE levels
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)
Hyperopia
Myopia
Psoriatic arthritis
Soluble leptin receptor levels
Cervical artery dissection
Heparin-induced thrombocytopenia
Hypertension (young onset)
Methotrexate phramacokinetics (acute lymphoblastic leukemia)
Response to interferon beta therapy
Response to antipsychotic therapy (extrapyramidal side effects)
Blood metabolite ratios
Response to inhaled corticosteroid treatment in asthma (change in FEV1)
Osteoarthritis (hip)
Sickle cell anemia (severity)
Openness
Conscientiousness
Agreeableness
Personality traits in bipolar disorder
Periodontal disease-related phenotype (Socransky)
Creatine kinase levels in statin users
Antinuclear antibody levels
Hypospadias
Naphthyl-keratin adduct levels
Alcohol dependence (age at onset)
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)
Drug-induced torsades de pointes
Non-small cell lung cancer (recurrence rate)
Vitamin D levels
Vitiligo
Plasma amyloid beta peptide concentrations (ABx-40)
Plasma amyloid beta peptide concentrations (ABx-42)
Hepatic lipid content in extreme obesity
Bilirubin levels in extreme obesity
Serologic markers in systemic lupus erythematosus
Chronic mucus hypersecretion
Inflammatory biomarkers in Kawasaki disease
HDL cholesterol (SNP x SNP interaction)
Response to diuretic therapy in hypertension
Thyroid peroxidase antibody positivity
Thyroid peroxidase antibody levels
Kidney function decline traits
Pulmonary emphysema
Lupus nephritis in systemic lupus erythematosus
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)
Immune response to measles-mumps-rubella vaccine
Methotrexate clearance (acute lymphoblastic leukemia)
Plasma thyroid-stimulating hormone levels
Pulse pressure (alcohol consumption interaction)
Systolic blood pressure (alcohol consumption interaction)
Diastolic blood pressure (alcohol consumption interaction)
Mean arterial pressure (alcohol consumption interaction)
Asthma (childhood onset)
Exfoliation glaucoma or exfoliation syndrome
Response to antipsychotic treatment
PCA3 expression level
Osteoarthritis
Non-alcoholic fatty liver disease histology (other)
Renal function and chronic kidney disease
Clubfoot
Autism spectrum disorder-related traits
Age-related cataracts
Age-related cataracts (age at onset)
Conduct disorder (symptom count)
Conduct disorder
Cortisol levels (plasma)
Asthma (corticosteroid response)
Electroencephalogram traits
Restless legs syndrome
Obesity-related traits
Abdominal aortic aneurysm
Cystic fibrosis severity
Birth length
Infant length
Plasma homocysteine levels (post-methionine load test)
Morphine dose requirement in tonsillectomy and adenoidectomy surgery
Asthma (sex interaction)
Type 2 diabetes (young onset) and obesity
Protein C levels
"Osteoarthritis (hand, severe)"
Chronic periodontitis
Peripheral artery disease
Response to statin therapy
Interferon alpha levels in systemic lupus erythematosus
Pneumoconiosis in silica exposure
Iron status biomarkers
Amyloid A serum levels
Musical aptitude
Airway responsiveness in chronic obstructive pulmonary disease
Fetal hemoglobin levels in sickle cell anemia
Fractional exhaled nitric oxide (childhood)
Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)
Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)
Enteric fever
Response to antiplatelet therapy
Response to TNF-alpha inhibitors in rheumatoid arthritis
Apolipoprotein Levels
Cholesterol and Triglycerides
CD4:CD8 lymphocyte ratio
CD3-positive T-lymphocyte count
CD4-positive T-lymphocyte count
CD8-positive T-lymphocyte count
CD19-positive B-lymphocyte count
CD56-positive NK-lymphocyte cell count
Response to radiotherapy in cancer (late toxicity)
Vitamin B levels in ischemic stroke
Sepsis from pneumonia (survival)
Hemoglobin A2 levels in sickle cell anemia
Thrombin generation potential phenotypes
Lipid traits
Anger
Autoimmune hepatitis type-1
Mitochondrial DNA levels
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)
Urinary bladder cancer
Maternal genotype effects in autism spectrum disorder families
Esophageal cancer
Chronic lymphocytic leukemia
Breast cancer (early onset)
Preschool internalizing problems
Pulmonary function
Urinary albumin excretion rate in type 1 diabetes
Amyotrophic lateral sclerosis or frontotemporal dementia
Inflammatory biomarkers
Bipolar disorder (body mass index interaction)
Kashin-Beck disease
Breast cancer (menopausal hormone therapy interaction)
Lobular breast cancer (menopausal hormone therapy interaction)
Cardiovascular event reduction in the elderly at risk for vascular disease (statin therapy interaction)
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
Glucose homeostasis traits
Serum IgA levels
Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)
Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid)
Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid)
Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid)
Hearing function
Laryngeal squamous cell carcinoma
Toenail selenium levels
Blood and toenail selenium levels
Osteoarthritis biomarkers
Generalized epilepsy
IgG levels
IgA levels
Response to taxane treatment (placlitaxel)
Response to taxane treatment (docetaxel)
Daytime sleep phenotypes
Night sleep phenotypes
Takotsubo syndrome
Bronchiolitis
Methadone dose in opioid dependence
Agoraphobic traits
Survival in breast cancer (TP53 expression interaction)
Survival in TP53 positive breast cancer
Liver injury in anti-retroviral drug treated HIV
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis
Cleft palate
Orofacial clefts
Cleft lip with or without cleft palate
Paneth cell defects in Crohn's disease
Nicotine metabolite ratio
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
Kidney disease (early and late stages) in type 1 diabetes
Kidney disease (early stage) in type 1 diabetes
Kidney disease (late stage) in type 1 diabetes
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes
Carotenoid levels (cryptoxanthin)
Carotenoid levels (alpha-carotene)
Vitamin E levels (alpha-tocopherol)
Carotenoid levels (beta-carotene)
Carotenoid levels (lutein)
Carotenoid levels (zeaxanthin)
Vitamin E levels (gamma-tocopherol)
Retinol levels
Otitis media
Otitis media (chronic)
Otitis media (recurrent)
Hepcidin/transferrin saturation ratio
Hepcidin/ferritin ratio
Hepcidin levels
Acute-on-chronic liver failure in hepatitis B
Self-reported tiredness
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)
Attention function
Liver injury in anti-tuberculosis drug treatment
Emotional dysregulation
Response to selective serotonin reuptake inhibitors in depression
Response to citalopram or escitalopram in depression
Response to antidepressants in depression
Non-response to bupropion and depression
Response to bupropion and depression
Response to selective serotonin reuptake inhibitors and depression
Non-response to citalopram or escitalopram and depression
Response to citalopram or escitalopram and depression
Non-response to antidepressants and depression
Non-response to selective serotonin reuptake inhibitors and depression
Response to antidepressants and depression
Response to bupropion in depression
Bone mineral density (femoral neck)
Bone mineral density (spine)
Arthritis (juvenile idiopathic)
Oropharynx cancer
Oral cavity cancer
Suicide behavior
Suicide ideation score in major depressive disorder
Suicide
Response to montelukast in asthma (change in FEV1)
Metastasis at diagnosis in osteosarcoma
Acute kidney injury in coronary artery bypass surgery (creatinine rise)
Advanced glycation end-product levels
Joint damage progression in ACPA-negative rheumatoid arthritis
Asthma exacerbations
Platinum-induced hepatotoxicity in non-small cell lung cancer
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)
Cardiomyopathy in childhood cancer survivors
Prostate cancer (survival)
LDL peak particle diameter (total fat intake interaction)
Dysphagia
Triptolide cytotoxicity
Spherical equivalent (joint analysis main effects and education interaction)
Diastolic blood pressure response to hydrochlorothiazide in hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension
Ideal cardiovascular health (clinical and behavioural)
Ideal cardiovascular health (clinical)
Pericardial adipose tissue adjusted for height and weight
Pericardial fat
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)
Visceral adipose tissue attenuation (Hounslow unit scale)
Neuroendocrine tumor
Small intestine neuroendocrine tumor
Pancreatic neuroendocrine tumor
Bronchial neuroendocrine tumor
Alcohol consumption (heavy vs. light/non-drinkers)
Life satisfaction
Positive affect
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)
Cardiovascular disease in hypertension (ACE inhibitor interaction)
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Myocardial infarction in hypertension (calcium channel blocker interaction)
Cardiovascular disease in hypertension (diuretic interaction)
Cardiovascular disease in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (ACE inhibitor interaction)
Myocardial infarction in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (diuretic interaction)
Pelvic organ prolapse
Pelvic organ prolapse (moderate/severe)
Plasma homocysteine levels
Aggressiveness in attention deficit hyperactivity disorder
Cannabis use
Response to interferon beta in multiple sclerosis
Response to fenofibrate (HDL cholesterol levels)
Response to fenofibrate (LDL cholesterol levels)
Response to fenofibrate (total cholesterol levels)
Response to fenofibrate (triglyceride levels)
High fetal hemoglobin in sickle cell disease
S-phenylmercapturic acid levels in smokers
Verbal-numerical reasoning
Educational attainment
Reaction time
Estrogen receptor status in HER2 positive breast cancer
Estrogen receptor status in HER2 negative breast cancer
Estrogen receptor status in breast cancer
EGFR mutation-positive lung adenocarcinoma
Asthma (SNP x SNP interaction)
Cluster headache
Serum parathyroid hormone levels
Heroin dependence
Urinary electrolytes (magnesium/calcium ratio)
Depressive symptoms measurement (somatic complaints domain)
Depressive symptoms measurement (lack of negative affect domain)
Depressive symptoms measurement (lack of positive affect domain)
QT interval (sulfonylurea treatment interaction)
JT interval (sulfonylurea treatment interaction)
QRS interval (sulfonylurea treatment interaction)
Type 2 diabetes (age of onset)
Response to clopidogrel therapy in coronary heart disease
Systolic blood pressure change trajectories
Pre-treatment pain in head and neck squamous cell carcinoma
Complex regional pain syndrome
Childhood onset asthma (traffic air pollution exposure interaction)
Post traumatic stress disorder symptom count in trauma-exposed individuals
Chronic venous disease
Ovarian disease with few adhesions
Deep ovarian and/or rectovaginal disease with dense adhesions
Adverse response to chemotherapy (congestive heart failure) in breast cancer
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications
Gallstone disease
Serum galactose-deficient IgA1 levels
Circulating chromogranin peptide levels
Pediatric bone mineral density (spine)
Pediatric bone mineral content (femoral neck)
Pediatric bone mineral density (femoral neck)
Pediatric bone mineral density (hip)
Pediatric bone mineral content (spine)
Pediatric bone mineral content (hip)
Early-onset Parkinson's disease
Alcohol misuse (trauma interaction)
Adult onset asthma (smoking interaction)
Adult onset asthma in non-smokers
Adult onset asthma in ever-smokers
Trans-epidermal water loss
Multiple system atrophy (pathologically confirmed)
Peak velocity of the mitral E-wave
Isovolumetric relaxation time
Peak velocity of excursion of lateral mitral annulus in early diastolic phase
Peak velocity of the mitral A-wave
Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.
Deceleration time of the mitral E-wave
Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave
Diastolic dysfunction with preserved ejection pressure
Heart failure with preserved ejection fraction
Aortic root size
Left atrial antero-posterior diameter
Left ventricle diastolic internal dimension
Left ventricle wall thickness
Left ventricular mass
Left ventricular fractional shortening
Left ventricle systolic dysfunction
Emphysema distribution in smoking
Lung function (FEV1)
Lung function (FVC)
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)
Nonsyndromic cleft lip with or without cleft palate
Hippocampal volume
Thyroid cancer
Age-related diseases and mortality
"Age-related diseases, mortality and associated endophenotypes"
Age-related disease endophenotypes
Essential tremor
Brain activation in response to working memory task
Hypothyroidism
Chin dimples
Allergy
Photic sneeze reflex
Menarche (age at onset)
Age at voice drop
Monobrow
Joint mobility (Beighton score)
Nose size
Hepatitis B (viral clearance)
QRS complex (12-leadsum)
QRS complex (Cornell)
QRS complex (Sokolow-Lyon)
L-arginine levels
Plasma t-tau levels
HIV progression (CD4 and viral load)
Iron status biomarkers (ferritin levels)
Iron status biomarkers (iron levels)
Iron status biomarkers (transferrin saturation)
Hip bone size adjusted for BMI
Fasting blood glucose adjusted for BMI
Anorectal malformation
Self-rated health
Bone mineral density or leg lean mass (pleiotropy)
Arm lean mass
Leg lean mass
Gut microbiota relative abundance (Bifidobacterium)
Gut microbiota relative abundance (Bacteroides)
Gut microbiota relative abundance (Parabacteroides)
Gut microbiota relative abundance (Prevotella)
Gut microbiota relative abundance (Streptococcus)
Gut microbiota relative abundance (unclassified genus belonging to family Clostridiaceae)
Gut microbiota relative abundance (unclassified genus belonging to the order Clostridiales)
Gut microbiota relative abundance (Ruminococcus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (Blautia)
Gut microbiota relative abundance (Coprococcus)
Gut microbiota relative abundance (Dorea)
Gut microbiota relative abundance (unassigned genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unclassified genus belonging to family Ruminococcaceae)
Gut microbiota relative abundance (Faecalibacterium)
Gut microbiota relative abundance (Oscillospira)
Gut microbiota relative abundance (Ruminococcus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unassigned genus belonging to family Clostridiales)
Gut microbiota relative abundance (Eubacterium belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (Sutterella)
Annualised percent change of cerebrospinal fluid AB1-42 levels
Hypopharyngeal or laryngeal cancer
Length of menstrual cycle
Male puberty timing (early vs. average onset facial hair)
Male puberty timing (late vs. average onset facial hair)
Male puberty timing (early vs. average onset voice breaking)
Male puberty timing (late vs. average onset voice breaking)
Male puberty timing (age at voice breaking MTAG)
Mitochondrial DNA copy number
Mitochondrial DNA copy number (white blood cells)
Factor VII activity or levels
Factor VII activity
Opioid overdose severity score
Autistic traits score (Social and Communication Disorders Checklist)
Simvastatin-induced myopathy
Atorvastatin-induced myopathy
Statin-induced myopathy (severe)
Statin-induced myopathy
Ceramide levels (C24:0)
Ceramide levels (C22:0)
Fractures (paediatric)
Opioid use disorder
Gut microbiota alpha diversity (Chao1 index)
Gut microbiota alpha diversity (PD_whole_tree index)
Gut microbiota alpha diversity (Shannon index)
Gut microbiota beta diversity (weighted UniFrac distance)
Schizophrenia or parental lifespan (pleiotropy)
Bipolar disorder or parental lifespan (pleiotropy)
Motor fluctuations in levodopa treated Parkinson's disease
Levodopa-induced dyskinesia in levodopa treated Parkinson's disease
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels
Anti-Kaposi's sarcoma associated herpesvirus ORF73 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K10.5 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K8.1 IgG levels
Corneal hysteresis
Corneal resistance factor
Interstitial lung diseases in rheumatoid arthritis
Anti-BK polyomavirus IgG seropositivity
BK polyomavirus VP1 antibody levels
Chlamydia trachomatis momp A antibody levels
Chlamydia trachomatis momp D antibody levels
Chlamydia trachomatis pGP3 antibody levels
Chlamydia trachomatis PorB antibody levels
Chlamydia trachomatis tarp-D F1 antibody levels
Chlamydia trachomatis tarp-D F2 antibody levels
Anti-cytomegalovirus IgG seropositivity
Cytomegalovirus pp28 antibody levels
Cytomegalovirus pp52 antibody levels
Cytomegalovirus pp150 antibody levels
Anti-Epstein-Barr virus IgG seropositivity
Epstein-Barr virus EA-D antibody levels
Epstein-Barr virus EBNA-1 antibody levels
Epstein-Barr virus VCA p18 antibody levels
Epstein-Barr virus ZEBRA antibody levels
Anti-human herpes virus 6 IgG seropositivity
Anti-human herpes virus 6 IE1A IgG seropositivity
Human herpes virus 6 IE1A antibody levels
Anti-human herpes virus 6 IE1B IgG seropositivity
Human herpes virus 6 IE1B antibody levels
Human herpes virus 6 p101k antibody levels
Anti-human herpes virus 7 IgG seropositivity
Cortical volume
Rapid automised naming of digits
Rapid automised naming of pictures
Short-term memory (digit-span task)
Non-word reading
Word spelling
Word reading
Phoneme awareness
Reading ability (multivariate)
Rapid automised naming of letters
Medial temporal lobe substructure volumes
Trigger finger
Human herpes virus 7 U14 antibody levels
Anti-helicobacter pylori IgG seropositivity
Helicobacter pylori CagA antibody levels
Helicobacter pylori Catalase antibody levels
Helicobacter pylori GroEL antibody levels
Helicobacter pylori OMP antibody levels
Helicobacter pylori UREA antibody levels
Helicobacter pylori VacA antibody levels
Anti-herpes simplex virus 1 IgG seropositivity
Herpes simplex virus 1 mgG-1 antibody levels
Anti-herpes simplex virus 2 IgG seropositivity
Herpes simplex virus 2 mgG-1 antibody levels
Anti-polyomavirus 2 IgG seropositivity
Polyomavirus 2 JC VP1 antibody levels
Anti-Merkel cell polyomavirus IgG seropositivity
Merkel cell polyomavirus VP1 antibody levels
Anti-Toxoplasma gondii IgG seropositivity
Toxoplasma gondii p22 antibody levels
Toxoplasma gondii sag1 antibody levels
Anti-varicella zoster virus IgG seropositivity
Varicella zoster virus glycoproteins E and I antibody levels
Corneal curvature
Viral basal core promoter double mutation in hepatitis B virus surface antigen (HBsAg) seropositivity
Response to esketamine in treatment resistant depression
Response to esketamine (responder status) in treatment resistant depression
Response to esketamine (remission) in treatment resistant depression
Brugada syndrome
Allergic march (atopic dermatitis to allergic rhinitis)
Allergic march (atopic dermatitis to asthma)
spontaneous preterm birth x maternal stress interaction (1df)
Lean nonalcoholic fatty liver disease
Social deprivation
Arrhythmia
Cataracts
Interstitial lung disease
Keloid
Nephrotic syndrome
Periodontal disease
Urolithiasis
Drug eruption
Pollinosis
Cerebral aneurysm
Congestive heart failure
Pulmonary tuberculosis
Biliary tract cancer
Hematological malignancy
Hepatocellular carcinoma
Carbamazepine-induced liver injury
Carbamazepine-induced reaction with eosinophilia and systemic symptoms
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Carbamazepine-induced serious cutaneous adverse reaction
Chronic widespread pain
Multisite chronic pain
Post-traumatic stress disorder (re-experiencing symptoms)
Sudden cardiac arrest in coronary artery disease
Carboplatin drug response (IC50)
Ara-C drug response (AUC)
Capecitabine drug response (AUC)
Cisplatin drug response (IC50)
Daunorubicin drug response (IC50)
Etoposide drug response (IC50)
Paclitaxel drug response (AUC)
Pemetrexed drug response (AUC)
First fracture in long-term childhood cancer survivors (time to event)
Visual contour integration
Anti-anoctamin 2 antibody levels
Adverse response to chemotherapy (amenorrhea) in breast cancer
"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)"
Percentage of invited food questionnaires completed
Acceptance of an invitation to wear a physical activity monitor
Acceptance of an invitation to participate in a mental health questionnaire
Completion of the aide-memoire
Participation in an health questionnaire (not invited vs invited)
Blood cell traits (multivariate analysis)
Emphysema annual change measurement in smokers (adjusted lung density)
Emphysema annual change measurement in smokers (percent low attenuation area)
Depressive symptoms x stressful life events interaction (1df test)
Depressive symptoms x stressful life events interaction (2df test)
Depressive symptoms x dependent stressful life events interaction (1df test)
Depressive symptoms x dependent stressful life events interaction (2df test)
Depressive symptoms x independent stressful life events interaction (1df test)
Depressive symptoms x independent stressful life events interaction (2df test)
Sedentary behaviour duration
Physical activity (walking duration)
Physical activity (moderate intensity activity duration)
Physical activity (overall physical activity time)
Myeloproliferative neoplasms
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)
Response to radiotherapy in prostate cancer (overall toxicity)
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)
same-sex sexual behaviour
proportion of same-sex sexual behaviour among non-heterosexuals
Diabetic kidney disease in diabetes
Chronic kidney disease in type 2 diabetes
Chronic kidney disease in diabetes
Chronic kidney disease and diabetic kidney disease in type 2 diabetes
Chronic kidney disease and diabetic kidney disease in diabetes
End-stage renal disease in type 2 diabetes
End-stage renal disease in diabetes
Late diabetic kidney disease in type 2 diabetes
Late diabetic kidney disease in diabetes
Early diabetic kidney disease in type 2 diabetes
Early diabetic kidney disease in diabetes
Glomerular filtration rate in type 2 diabetes
Glomerular filtration rate in diabetes
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)
Diabetic kidney disease in diabetes (ESRD vs. no ESRD)
Diabetic kidney disease in type 2 diabetes
Serum oxytocin levels
Fasting blood proinsulin levels
Insulinogenic index
Proinsulin levels (late-phase conversion)
Proinsulin levels (early-phase conversion)
Anti-drug antibodies in autoimmune disease (time to event)
Airway obstruction (FEV1/FVC<70%) in never smokers
Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers
Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers
Airway obstruction (FEV1/FVC<70%) in ever smokers
Pandemrix-induced narcolepsy
Particulate matter induced DNA damage
Bitter alcoholic beverage consumption
Bitter non-alcoholic beverage consumption
Tea consumption
Grapefruit juice consumption
Sweet beverage consumption
Sugar-sweetened beverage consumption
Artificially sweetened beverage consumption
Pure non-grapefruit juice consumption
Bitter beverage consumption
Severe depressive disorders in coronary artery disease
Osteoarthritis of the hip or knee
Breast cancer (male)
Tuberculosis (SNP x SNP interaction)
Type 2 diabetes nephropathy including microalbuminuria
Resistant hypertension
beta-lactam allergy measurement
Thiopurine-induced early leukopenia in Crohn's disease
Acute post-radiotherapy pain in breast cancer
Circulating fibroblast growth factor 21 levels
Circulating fibroblast growth factor 23 levels
Age at menopause
Intraocular pressure (corneal compensated)
Intraocular pressure (Goldman correlated)
Corneal endothelial cell density
Corneal endothelial cell size variation coefficient
Corneal endothelial cell shape (percentage of hexagonally shaped cells)
Urine specific gravity measurement
Glucosuria (moderate to severe)
Glucosuria (mild)
Ketonuria
Ketonuria (moderate to severe)
Ketonuria (mild)
Proteinuria
Proteinuria (moderate to severe)
Proteinuria (mild)
Hematuria
Hematuria (moderate to severe)
Hematuria (mild)
Urine pH measurement
Low urine pH
Signs of urinary tract infection (nitrites and leukocyte esterase)
Glucosuria
Cognitive impairment and LDL levels (pleiotropy)
Cognitive impairment and total cholesterol levels (pleiotropy)
Cognitive impairment
Serum total cholesterol levels
Cognitive impairment and C-reactive protein levels (pleiotropy)
Mild cognitive impairment
Amyloid status (abnormal vs normal)
Central cerebrospinal fluid amyloid beta 42 to 40 ratio (abnormal vs normal)
Local cerebrospinal fluid amyloid beta 42 levels (abnormal vs normal)
Amyloid pathology
Central cerebrospinal fluid amyloid beta 42 levels
Central cerebrospinal fluid amyloid beta 38 levels
Central cerebrospinal fluid amyloid beta 40 levels
Central cerebrospinal fluid amyloid beta 42 to 40 ratio
Local cerebrospinal fluid t-tau levels (abnormal vs normal)
Local cerebrospinal fluid p-tau levels (abnormal vs normal)
Cerebrospinal fluid p-tau levels
Alzheimer's disease or family history of Alzheimer's disease
Family history of Alzheimer's disease
Sensation seeking
Impulsivity
Lack of premeditation
Positive urgency
Negative urgency
Lack of perseverance
Impulsivity (attentional)
Impulsivity (motor)
Impulsivity (non-planning)
Drug experimentation measurement
Aspartate aminotransferase levels in non-alcoholic fatty liver disease
Alanine aminotransferase levels in non-alcoholic fatty liver disease
Nonalcoholic fatty liver disease (SNP x SNP interaction)
Meningococcal C IgG concentrations post childhood immunization
Meningococcal C functional antibody titers post childhood immunization
Tetanus toxoid IgG concentrations post childhood immunization
Haemophilus influenza type b polyribosylribitol phosphate IgG concentrations post childhood immunization
Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention)
Breakfast cereal skipping frequency
Breakfast skipping
Difficulty awakening
Cardiometabolic traits
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A
Psychological distress
Neurological blood protein biomarker levels
Varicose veins
Substance use disorder
NHDL cholesterol levels
Pyridoxal 5'-phosphate levels
Plasma pyridoxal phosphate to pyridoxal ratio
Pyridoxal levels
4-pyridoxic acid levels
PAr index (pyridoxic acid/(pyridoxal 5′-phosphate + pyridoxal))
Malaria
Asthma (time to childhood onset) in early life tobacco smoke exposure
Asthma (time to childhood onset) x early life tobacco smoke interaction
Anti-sp100 seropositivity in primary biliary cholangitis
Anti-gp210 seropositivity in primary biliary cholangitis
Coffee consumption (cups per day)
Estimated glomerular filtration rate
Glycosuria in pregnancy (maternal genotype effect)
Glycosuria in pregnancy (offspring genotype effect)
Glycosuria in pregnancy (maternal and offspring genotype effect)
Keratoconus
Chronic kidney disease x type 2 diabetes interaction
Peripheral arterial disease x type 2 diabetes interaction
Coronary heart disease x type 2 diabetes interaction
Acute ischemic stroke x type 2 diabetes interaction
Retinopathy x type 2 diabetes interaction
Neuropathy x type 2 diabetes interaction
Chemerin levels
Metabolic coherence (transcriptomic)
Emotional lability
Lack of behavioral control
Type A behavior
Locus of control over disease
Psychoticism
Fasting plasma glycodeoxycholate 3-O-glucuronide concentration
Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration
Adult asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome
Motor composite score
Mental composite score
Left ventricular mass to end-diastolic volume ratio
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Left ventricular global circumferential strain
Left ventricular global radial strain
Left ventricular global longitudinal strain
Hypertrophic cardiomyopathy (MTAG)
Left ventricular ejection fraction (MTAG)
Left ventricular mass to end-diastolic volume ratio (MTAG)
Left ventricular mass (MTAG)
Left ventricular end-diastolic volume (MTAG)
Left ventricular end-systolic volume (MTAG)
Left ventricular global circumferential strain (MTAG)
Left ventricular global radial strain (MTAG)
Left ventricular global longitudinal strain (MTAG)
Left ventricle wall thickness (MTAG)
Hypertrophic cardiomyopathy
Latent autoimmune diabetes
Latent autoimmune diabetes vs. type 2 diabetes
Latent autoimmune diabetes vs. type 1 diabetes
Eyebrow thickness
Delayed reward discounting
Paediatric migraine
Triglyceride levels (parental genotype effect)
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)
Triglyceride change in response to fenofibrate (parental genotype effect)
Triglyceride levels in response to fenofibrate
Triglyceride change in response to fenofibrate treatment
Hypersomnia (HLA-DQB1*06:02 negative)
Cotinine levels in smokers with chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease
Digit length ratio (right hand)
Digit length ratio
Digit length ratio (left hand)
Emotional support seeking
Positive reappraisal
Problem solving
Disengagement
Emotional coping (emotional expression/emotional support seeking)
Approach coping (positive reappraisal/problem solving)
Perceived stress
Emotional expression
Urinary albumin excretion (no hypertensive medication)
Urinary albumin excretion
Carotid intima media thickness in rheumatoid arthritis
Cardiovascular event in rheumatoid arthritis
Ischemic heart disease in rheumatoid arthritis
Carotid plaques in rheumatoid arthritis
Lateral ventricular volume in normal aging
BRCA1 mutation in breast cancer
BRCA2 mutation in breast cancer
Affective disorder and suicide attempts
Delirium
Well-being spectrum (multivariate analysis)
Nonsyndromic cleft palate
Anthropometric traits (multi-trait analysis)
Anthropometric traits
Disorders of lipid metabolism
Eye color traits
Skin pigmentation traits
Hair morphology traits
Handedness
Response to lurasidone in schizophrenia
Myopic maculopathy
Extremely high intelligence
Endometrial cancer (endometrioid histology)
Endometrial cancer (Non-endometrioid histology)
Testicular cancer
Oral cavity and pharyngeal cancer
Esophageal or stomach cancer
Lymphocytic leukemia
Kidney cancer
Non-Hodgkin's lymphoma
Cancer (pleiotropy)(bidirectional)
Cryptococcosis in HIV infection
Barrett's esophagus or esophageal adenocarcinoma x sex interaction (1df test)
Barrett's esophagus or esophageal adenocarcinoma x sex interaction (2df test)
Walking pace
Colorectal cancer x fine particulate matter exposure levels interaction
Inflammatory biomarkers (multivariate analysis)
Carotenoid levels
Diabetes biomarker traits
Hematology traits
Hormone measurements
Circulating inorganic ion levels
Lipid or lipoprotein levels
Renal system biomarkers
Vitamin levels
Severe diabetic retinopathy in type 2 diabetes
Kawasaki disease
Premature ovarian failure
Total body bone mineral density
Ulna and radius bone mineral density
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
Homocysteine level response to multivitamin in cerebral infarction
Red blood cell folate levels
Femoral neck bone mineral density or type 2 diabetes (pleiotropy)
Adenocarcinoma in never smokers
Parkinson's disease (age at diagnosis)
Smoking status (current vs mixed)
Cigarettes smoked per day (current)
Cigarettes smoked per day (past)
Smoking status (current vs never)
Hyperglycemia
Hyperglycemia in obesity
Hyperglycemia in non-obese individuals
Hyperglycemia in lower physical activity
Hyperglycemia in higher physical activity
Hyperglycemia in more-fat diet
Hyperglycemia in less-fat diet
Homeostasis model assessment of insulin resistance in obesity
Homeostasis model assessment of insulin resistance in non-obese individuals
Homeostasis model assessment of insulin resistance in higher physical activity
Homeostasis model assessment of insulin resistance in lower physical activity
Homeostasis model assessment of insulin resistance in more-fat diet
Homeostasis model assessment of insulin resistance in less-fat diet
Hyperglycemia x BMI interaction
Hyperglycemia x physical activity interaction
Hyperglycemia x saturated fatty acids interaction
Hyperinsulinemia
Hyperinsulinemia x BMI interaction
Homeostasis model assessment of insulin resistance x BMI interaction
Hyperinsulinemia x physical activity interaction
Homeostasis model assessment of insulin resistance x physical activity interaction
Hyperinsulinemia x saturated fatty acids interaction
Homeostasis model assessment of insulin resistance x saturated fatty acids interaction
Hyperinsulinemia in obesity
BRCA1/2-negative high-risk breast cancer
Hyperinsulinemia in non-obese individuals
Hyperinsulinemia in higher physical activity
Hyperinsulinemia in lower physical activity
Hyperinsulinemia in more-fat diet
Hyperinsulinemia in less-fat diet
Alcohol use disorder (total score)
Alcohol use disorder (consumption score)
Alcohol use disorder (dependence and problematic use scores)
Hip shape (DXA scan)
Intra-individual response time variability (response selection)
Intra-individual response time variability (selective attention)
Serum 25-Hydroxyvitamin D levels
Early chronic obstructive pulmonary disease in never smokers
Early chronic obstructive pulmonary disease
Fasting glucose in pregnancy (gestational week 14-16)
Fasting glucose in pregnancy (gestational week 30-32)
Two-hour glucose in pregnancy (gestational week 14-16)
Two-hour glucose in pregnancy (gestational week 30-32)
General glucose level in pregnancy (gestational week 14-16)
General glucose level in pregnancy (gestational week 30-32)
Timing of glucose curve peak in pregnancy (gestational week 14-16)
Timing of glucose curve peak in pregnancy (gestational week 30-32)
Chronic periodontitis (slight)
Chronic periodontitis (severe)
Chronic periodontitis (generalised)
Chronic periodontitis (localised)
Composite immunoglobulin trait (IgA x IgG x IgM)
Composite immunoglobulin trait (IgA x IgG/IgM)
Composite immunoglobulin trait (IgA x IgG)
Composite immunoglobulin trait (IgA/IgG)
Composite immunoglobulin trait (IgA/IgM)
Composite immunoglobulin trait (IgG/IgM)
IgM levels
Frontal fibrosing alopecia
Psychological resilience (outcome-based) in high deployment stress exposure
Psychological resilience (self-assessed)
Psychological resilience (outcome-based)
Sleep duration (short sleep)
Sleep duration (long sleep)
Cutaneous leishmaniasis
Coronary artery disease in type 1 diabetes
Diverticular disease
Diverticulitis
Asthma with severe exacerbations
coronary artey disease and insomnia (pleiotropy)
coronary artery disease and sleep duration (pleiotropy)
coronary artery disease and chronotype (pleiotropy)
Hypospadias (moderate to severe)
Early age-related macular degeneration
Facial pigmentation measurement (UV light)
Facial pigmentation measurement (polar light)
Lung function x fine particulate matter exposure levels interaction
Sodium levels in epilepsy
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine-induced hyponatremia in epilepsy
Oxcarbazepine-induced hyponatremia in epilepsy
"Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy"
Pulse rate
Bronchodilator response x age interaction in asthma
Serum galactose-deficient IgA1 levels in IgA nephropathy
Alzheimer's disease or cardiovascular risk factors (pleiotropy)
Suicidal ideation
Hepatitis B virus-related hepatocellular carcinoma
Sphingolipid d18:1/d18:2 ratio
Microscopic colitis in proton-pump inhibitor treatment
Microscopic colitis
Peptic ulcer disease
Gastroesophageal reflux disease
"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment"
Academic attainment (English)
Academic attainment (maths)
Academic attainment (science)
joint destruction in rheumatoid arthritis (rapid vs slow)
Triiodothyronine levels
Thyroxine levels
Triiodothyronine levels and thyroxine levels
Carpal tunnel syndrome
Serum urate levels in chronic kidney disease
Gout in chronic kidney disease
Nose wing breadth
Nose length
Nosetip height
Nasal root breadth
Nasal root height
Eye length
Interorbital distance
Labial fissure length
Lip thickness
Lower face length
Brow ridge morphology (principal component model)
Eye morphology (principal component model)
Side of face morphology (principal component model)
Cheek morphology (principal component model)
Nose morphology (principal component model)
Mouth morphology (principal component model)
Brow ridge morphology (partial least square model)
Eye morphology (partial least square model)
Side of face morphology (partial least square model)
Cheek morphology (partial least square model)
Nose morphology (partial least square model)
Mouth morphology (partial least square model)
Addison's disease
Postburn scar height
Postburn scar pliability
Seasonality in depression
Seasonality and depression
Low density lipoprotein triglyceride levels
Maternal chorioamnionitis
Body size at age 10
Adult body size
Cerebral microbleeds
Cerebral microbleeds (lobar)
Cerebral microbleeds (mixed)
Longevity
Fish consumption
Metabolic syndrome (multivariate analysis)
Acute lymphoblastic leukemia in childhood (B cell precursor)
Hip bone mineral density and total body fat mass (bivariate analysis)
Change in HbA1c levels in response to metformin treatment in type 2 diabetes
Falling risk
Facial wrinkles
Plasma renin activity levels
Response to hepatitis B vaccine
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
Eye movement (horizontal position gain)
Eye movement in schizophrenia (scanpath length)
Eye movement (scanpath length)
Eye movement in schizophrenia (duration of fixations)
Eye movement (duration of fixations)
Eye movement in schizophrenia (integrated eye movement score)
Eye movement (integrated eye movement score)
Eye movement in schizophrenia (horizontal position gain)
Major depressive disorder (probable)
Major depressive disorder (ICD-10 coded)
Depression (broad)
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
Healthspan
Eudaimonic well-being
Hedonic well-being
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)
Erectile dysfunction
Brain imaging measurements
Small subcortical brain infarct
Brain infarct
Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Offspring birth weight
Response to ranibizumab in age-related macular degeneration (exudative)
Remission after SSRI treatment in major depression
Diffusing capacity of the lung for carbon monoxide traits
Socioeconomic status of place of residence
Population density of place of residence
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity
Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity
Anti-influenza A virus IgG seropositivity
Anti-measles virus IgG seropositivity
Anti-mumps virus IgG seropositivity
Anti-rubella virus IgG seropositivity
Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity
Anti-hepatitis B virus core antigen (HBc) IgG seropositivity
Anti-cytomegalovirus IgG levels
Anti-Epstein-Barr virus early antigen (EA) IgG levels
Anti-herpes simplex virus 1 IgG levels
Anti-herpes simplex virus 2 IgG levels
Anti-varicella zoster virus IgG levels
Anti-helicobacter pylori IgG levels
Anti-Toxoplasma gondii IgG levels
Anti-influenza A virus IgG levels
Anti-measles virus IgG levels
Anti-mumps virus IgG levels
Anti-rubella virus IgG levels
Anti-hepatitis B virus surface antigen (HBs) IgG levels
Anti-hepatitis B virus core antigen (HBc) IgG levels
Relative amplitude of rest-activity cycles
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
Upper eyelid sagging severity
Lung cancer (SNP x SNP interaction)
Guillain-Barré syndrome
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)
Uterine fibroid size (maximum dimension)
Bronchodilator response in asthma
Initial alcohol sensitivity
Response to opioid analgesics in cancer (pain decrease)
Osteolysis in total hip arthroplasty
Osteolysis in total hip arthroplasty (time to prosthesis revision)
Handedness (Left-handed vs. non-left-handed)
Handedness (Right-handed vs. non-right-handed)
Ambidextrousness
Postoperative survival time in hepatocellular carcinoma
Breast cancer specific mortality in breast cancer
Breast cancer specific mortality in estrogen receptor negative breast cancer
Breast cancer specific mortality in estrogen receptor positive breast cancer
Visceral fat
Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)
Chronic obstructive pulmonary disease or stroke (pleiotropy)
Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)
Tinnitus in cisplatin-treated testicular cancer
Lumbar spine bone mineral density (trabecular)
Lumbar spine bone mineral density (integral)
Sleep duration (variability)
Sleep efficiency
Sleep (number of episodes)
Sleep (time to least active 5 hours)
Time to most active 10 hours
Sleep (time to midpoint)
Diurnal inactivity
Response to intravenous immunoglobulin treatment in Kawasaki disease
Facial attractiveness (female raters)
Facial attractiveness (male raters)
Executive function (trail making test B)
Perceptual and visual search speed and executive function (trail making test BA)
perceptual and visual search speed (trail making test A) (age interaction)
Executive function (trail making test B) (age interaction)
Perceptual and visual search speed and executive function (trail making test BA) (age interaction)
perceptual and visual search speed (trail making test A)
Tramadol metabolism (O-desmethyltramadol to tramadol ratio)
Leisure-time exercise behaviour
Leisure-time exercise behaviour (age-stratified)
Cognitive flexibility
Philtrum width
Nicotine dependence and major depression (severity of comorbidity)
Anorexia nervosa or obsessive-compulsive disorder
Post bronchodilator percent predicted FEV1 in smoking
Post bronchodilator FEV1/FVC ratio in smoking
Obesity without metabolic disease
Sexual/religious dimension in obsessive compulsive disorder
Worry/vulnerability (special factor of neuroticism)
Anxiety/tension (special factor of neuroticism)
General factor of neuroticism
RR interval (heart rate)
Plasma anastrozole concentration in anastrozole-treated estrogen receptor positive breast cancer
Asthma (adult onset)
Asthma onset (childhood vs adult)
Cardiac Troponin-T levels
Cardiac troponin-I levels
Plantar fascial disorders
Aortic coarctation
Clostridium difficile infection in multiple myeloma
Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension
Lipid traits (pleiotropy) (HIPO component 1)
Lipid traits (pleiotropy) (HIPO component 2)
Social science traits (pleiotropy) (HIPO component 1)
Osteoarthritis (self-reported)
Osteoarthritis of the hip (hospital diagnosed)
Osteoarthritis (hospital diagnosed)
Osteoarthritis of the knee (hospital diagnosed)
Osteoarthritis of the hip or knee (hospital diagnosed)
Antidepressant treatment resistance (> 2 drugs prescribed)
Antidepressant treatment resistance (number of drugs prescribed)
Asthma control x inhaled corticosteroid treatment interaction (2df)
Asthma control x inhaled corticosteroid treatment interaction (1df)
Asthma control
Cholesterol efflux capacity
Cholesterol efflux capacity (cAMP stimulated assay)
Cholesterol efflux capacity (ABCA-1 dependent assay)
Cholesterol efflux capacity (BHK stimulated assay)
Nontyphoidal Salmonella bacteraemia
Ventricular ectopy or supraventricular ectopy (pleiotropy)
Ventricular ectopy
Supraventricular ectopy
Low white blood cell count
Low white blood cell count (conditioned on rs2814778)
Warfarin-associated bleeding
Response to long-term oxygen therapy in chronic obstructive pulmonary disease
Anxiety disorder or brain volume (pleiotropy)
Post-traumatic stress disorder or brain volume (pleiotropy)
Diffusing capacity of carbon monoxide
Asthma exacerbations in inhaled corticosteroid treatment
Body mass index and waist-hip ratio (pleiotropy)
Cortical amyloid beta load
Alzheimer's disease progression score
Cannabis-related aggression
Cerebral amyloid deposition (PET imaging)
Multiple traits (pleiotropy)
Tourette syndrome or brain region volumes (pleiotropy)
Social disinhibition in Tourette syndrome or subcortical volume measurements (pleiotropy)
Symmetry behaviour in Tourette syndrome or subcortical volume measurements (pleiotropy)
Growth differentiation factor-15 levels
Cognitive disorganisation
Parent-rated negative symptoms
Paranoia and hallucinations
Idiopathic intracranial hypertension
Global electrical heterogeneity phenotypes
visceral adipose tissue/total adipose tissue ratio
Neuropathic pain in head and neck cancer
Non-steroidal anti-inflammatory drug-induced enteropathy
Brain morphology (MOSTest)
Cortical thickness (MOSTest)
Subcortical volume (MOSTest)
Brain morphology (min-P)
Cortical surface area (MOSTest)
Subcortical volume (min-P)
Cortical surface area (min-P)
Cortical thickness (min-P)
High IL-1beta levels in gingival crevicular fluid
Severe aortic features in Marfan syndrome
Vestibular neuritis
Waist-to-hip ratio adjusted for BMI (recessive genetic model)
Waist-to-hip ratio adjusted for BMI (additive genetic model)
Progressive supranuclear palsy
Pemphigus vulgaris
Pemphigus foliaceus
Developmental dysplasia of the hip
Bronchopulmonary dysplasia in preterm infants
Plasma parathyroid hormone levels
Energy expenditure
Energy intake
Type 2 diabetes or coronary artery disease (pleiotropy)
Prostate cancer mortality
Anhedonia in major depressive disorder
Midgestational cytokine/chemokine levels (maternal genetic effect)
Neonatal cytokine/chemokine levels (maternal genetic effect)
Midgestational cytokine/chemokine levels (fetal genetic effect)
Neonatal cytokine/chemokine levels (fetal genetic effect)
Rumination (response to stress)
Brooding (response to stress)
Reflection (response to stress)
Serum erythropoietin levels
Thrombocytopenia in coronary artery bypass surgery
Severe cutaneous adverse drug reactions
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer
Glomerular filtration rate change in heart transplantation
Total hippocampal volume
Presubiculum volume (corrected for total hippocampal volume)
Subiculum volume (corrected for total hippocampal volume)
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)
Hippocampal subfield CA3 volume (corrected for total hippocampal volume)
Hippocampal subfield CA4 volume (corrected for total hippocampal volume)
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)
Hippocampal fissure volume (corrected for total hippocampal volume)
Hippocampal tail volume (corrected for total hippocampal volume)
Fimbria volume (corrected for total hippocampal volume)
HATA volume (corrected for total hippocampal volume)
Parasubiculum volume (corrected for total hippocampal volume)
Presubiculum volume
Subiculum volume
Hippocampal subfield CA1 volume
Hippocampal subfield CA3 volume
Hippocampal subfield CA4 volume
Dentate gyrus granule cell layer volume
Dentate gyrus molecular layer volume
Hippocampal fissure volume
Hippocampal tail volume
Fimbria volume
HATA volume
Parasubiculum volume
Thyroid nodules
Biliary atresia
Sudden cardiac arrest
Pediatric areal bone mineral density (concordant skeletal phenotype)
Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype)
Pediatric areal bone mineral density (spine vs radius & hip discordant skeletal phenotype)
Blood pressure x alcohol consumption interaction
Blood pressure (smoking interaction)
Diarrhoea-associated Entamoeba histolytica infection
Anti-thyroid peroxidase (TPOAb) levels in Hashimoto's thyroiditis
Anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis
Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto's thyroiditis
Coronary heart disease events during statin therapy
Soluble E-selectin levels
Soluble ICAM-1
Soluble VCAM-1 levels
Interleukin-1-alpha levels
Soluble CD40 ligand levels
Thyrotoxic hypokalemic periodic paralysis in Graves disease
Thyrotoxic hypokalemic periodic paralysis and Graves disease
Depression in smokers
Urinary potassium to creatinine ratio
Urinary sodium to creatinine ratio
Urinary sodium to potassium ratio
Albuminuria
Growth differentiation factor-15 levels (conditioned on rs888663)
Resting-state electroencephalogram vigilance
Renal cell carcinoma x sex interaction
Estimated glomerular filtration rate after 1 year in renal transplantation (donor effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (recipient effect)
Estimated glomerular filtration rate after 5 years in renal transplantation (donor effect)
Estimated glomerular filtration rate change in renal transplantation (recipient effect)
Estimated glomerular filtration rate change in renal transplantation (donor effect)
Estimated glomerular filtration rate after 1 year in renal transplantation (recipient effect)
Perceptual rivalry (Necker cube stimulus)
Perceptual rivalry (voluntary modulation strength)
Perceptual rivalry (binocular rivalry task)
"Type 2 diabetes (SNP x SNP interaction, 2df)"
"Type 2 diabetes (SNP x SNP interaction, 1df)"
Femoral neck size
Trochanter size
Intertrochanteric region size
Spine bone size
Plasma norclozapine levels in treatment-resistant schizophrenia
Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia
Plasma clozapine levels in treatment-resistant schizophrenia
Severe coronary artery calcification
Self-reported childhood asthma in adult smokers
Sural nerve amplitude potential
Sural nerve conduction velocity
Benign prostatic hyperplasia
Anti-adalimumab antibody production in response to treatment in Crohn's disease
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)
Cognitive ability in schizophrenia
Cerebrospinal fluid sTREM-2 levels
Glycemic traits (pleiotropy)
Bisphosphonate-associated atypical femoral fracture
Atypical femoral fracture in phosphonate treatment
KANNO antigen negativity
Severity of nausea and vomiting of pregnancy
Hyperemesis gravidarum
Anxiety and stress-related disorders
Stress-related disorders
Anxiety and stress-related disorders (excluding adjustment disorder)
Anxiety and stress-related disorders (excluding co-morbid schizophrenia)
Anxiety and stress-related disorders (including obsessive-compulsive disorder)
Anxiety and stress-related disorders (psychiatric co-morbidity weighting design)
Anxiety and stress-related disorders (psychiatric co-morbidity covariate model)
Anxiety and stress-related disorders (propensity-score-matching design)
Low susceptibility to hepatitis C infection
Psychological wellbeing index 1 (lack of subjective wellbeing and health)
Psychological wellbeing index 3 (fatigue and loss of appetite)
Psychological wellbeing index 12 (lack of enjoying daily life)
Psychological wellbeing (social role performance and self-confidence)
Psychological wellbeing (depressiveness)
Psychological wellbeing (health and vitality)
Psychological wellbeing index (total score)
Post-traumatic stress disorder symptoms in trauma-exposed soldiers
Glioma (pediatric/youth onset)
Liver iron content
Gemcitabine-induced early high-grade neutropenia in pancreatic cancer
Coronary artery disease in type 2 diabetes
Coronary artery disease in individuals without type 2 diabetes
Coronary artery disease x type 2 diabetes interaction
Electrocardiographic traits (multivariate)
PR segment duration
ST segment duration
T wave duration
TP segment duration
Neutrophil level response to clozapine in treatment-resistant schizophrenia
Skin reflectance (Melanin index)
Morning person
Cardiovascular disease in type 2 diabetes
Adverse response to antithyroid drugs in Graves disease
Skin hydration
Plasma factor VII activating protease levels
Calcaneus stiffness index
Remission after antidepressant treatment in major depression
Response to antidepressants (symptom improvement)
Warfarin maintenance dose (adjusted for clinical factors)
Shoulder impingement or rotator cuff tear
Shoulder impingement
Chronic central serous retinopathy
Attention deficit hyperactivity disorder symptom score
Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy
Suicide attempt severity
Anti-Mullerian hormone levels in pre-menopausal women of late reproductive age
Radioiodine-refractory disease in thyroid cancer
Voxel-wise structural brain imaging measurements
Breast cancer and/or colorectal cancer
Pre-treatment viral load in HIV-1 infection
Primary central nervous system lymphoma
Emotional lability in attention deficit hyperactivity disorder
Number of twin births
BMI at birth
BMI at 6 weeks old
BMI at 3 months old
BMI at 6 months old
BMI at 8 months old
BMI at 1 year old
BMI at 1.5 years old
BMI at 2 years old
BMI at 3 years old
BMI at 5 years old
BMI at 7 years old
BMI at 8 years old
Adult hearing difficulty
Adult hearing aid use
Percent glycated albumin
Total glycated albumin levels
Fructosamine levels
Type 2 diabetes and end-stage kidney disease
Type 2 diabetes and end-stage kidney disease in APOL1 risk genotype negative individuals
Alcohol dependence (tolerance)
Alcohol dependence (withdrawal)
Alcohol dependence (drinking more than intended)
Alcohol dependence (desire to cut drinking)
Alcohol dependence (giving up activities)
Alcohol dependence (time spent drinking)
Alcohol dependence (drinking despite problems)
Alcohol or illicit drug dependence
Thyroglobulin plasma levels
Right-sided colonic diverticulosis
Bicuspid aortic valve
Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)
Medication use (drugs used in diabetes)
Medication use (antithrombotic agents)
Medication use (vasodilators used in cardiac diseases)
Medication use (antihypertensives)
Medication use (diuretics)
Medication use (beta blocking agents)
Medication use (calcium channel blockers)
Medication use (agents acting on the renin-angiotensin system)
Medication use (HMG CoA reductase inhibitors)
Medication use (thyroid preparations)
Medication use (immunosuppressants)
"Medication use (anti-inflammatory and antirheumatic products, non-steroids)"
Medication use (drugs affecting bone structure and mineralization)
Medication use (opioids)
Medication use (salicylic acid and derivatives)
Medication use (anilides)
Medication use (antimigraine preparations)
Medication use (antidepressants)
"Medication use (adrenergics, inhalants)"
Medication use (glucocorticoids)
Medication use (antihistamines for systemic use)
Medication use (antiglaucoma preparations and miotics)
Cellular nuclear factor (erythroid-derived 2)-like 2 levels
Metastasis in stage I-III microsatellite instability low/stable colorectal cancer (time to event)
Geographic atrophy lesion growth rate in age-related macular degeneration
Sero-negative rheumatoid arthritis
Obesity (extreme) (SNP x SNP interaction)
Bioavailable testosterone levels
Estradiol levels
Sex hormone-binding globulin levels adjusted for BMI
Sex hormone-binding globulin levels
Total testosterone levels
Asthma (age of onset)
Obesity and osteoporosis
Prion diseases
Arterial stiffness
Vitiligo (non-segmental)
Diabetic retinopathy
C4b binding protein levels
Tanning
Biochemical measures
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Radiation response
Response to hepatitis C treatment
Response to metformin in type 2 diabetes (glycemic)
Lp (a) levels
Hoarding
Personality dimensions
Anti-cyclic Citrullinated Peptide Antibody
Blue vs. green eyes
Burning and freckling
Blond vs. brown hair color
Red vs. non-red hair color
Response to anti-TNF therapy in rheumatoid arthritis
Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
Lipoprotein-associated phospholipase A2 activity and mass
Metabolic traits
Immunoglobulin A
Body mass in chronic obstructive pulmonary disease
Orofacial clefts (maternal alcohol consumption interaction)
HIV-1 control
Congenital heart malformation
Adiposity
Cardiac hypertrophy
Cutaneous nevi
Response to lithium treatment in bipolar disorder
Glomerulosclerosis
Fat intake
Amyotrophic lateral sclerosis (SNP x SNP interaction)
Homeostasis model assessment of beta-cell function
Phytosterol levels
Idiopathic membranous nephropathy
Hepatitis C induced liver cirrhosis
Ribavirin-induced anemia
Hearing impairment
Response to citalopram treatment
Waist circumference and related phenotypes
AIDS
Menarche and menopause (age at onset)
Methamphetamine dependence
Drug-induced liver injury (flucloxacillin)
Hippocampal atrophy
Monocyte early outgrowth colony forming units
Major depressive disorder (broad)
Response to platinum-based chemotherapy in head and neck cancers
Frontotemporal lobar degeneration
Non-small cell lung cancer
Major mood disorders
Speech perception in dyslexia
Electrocardiographic traits
Neuroticism (age interaction)
Myocardial infarction in coronary artery disease
Emphysema-related traits
Pseudoexfoliation syndrome
Nephrotic syndrome (acquired)
Nevus count
Alzheimer's disease biomarkers
Multiple sclerosis (severity)
Creutzfeldt-Jakob disease
Brain cytoarchitecture
Two-hour glucose challenge
Response to treatment for acute lymphoblastic leukemia
Asthma (toluene diisocyanate-induced)
Lumiracoxib-related liver injury
Angiotensin-converting enzyme activity
Inflammatory bowel disease (early onset)
Otosclerosis
Moyamoya disease
Polyunsaturated fatty acid levels
HIV-1 replication
Body mass index and fat mass
Coagulation factor levels
Male infertility
Smoking behavior
Type 1 diabetes autoantibodies
Bitter taste response
Body mass (lean)
Malignant pleural mesothelioma
Brachial circumference
Helicobacter pylori serologic status
Dupuytren's disease
Cardiac structure and function
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)
Bipolar disorder and schizophrenia
Lentiform nucleus volume
Chronic fatigue syndrome
Cataracts in type 2 diabetes
Renal function-related traits (BUN)
Renal function-related traits (sCR)
Renal function-related traits (eGRFcrea)
Renal function-related traits (urea)
Permanent tooth development
Factor XI
Pit-and-Fissure caries
Smooth-surface caries
HIV-1 susceptibility
Aging (facial)
Schizophrenia (negative symptoms)
Circulating vasoactive peptide levels
End-stage coagulation
Response to diuretic therapy
Blood trace element (Se levels)
Blood trace element (Cu levels)
Blood trace element (Zn levels)
Metabolite levels
Lipid metabolism phenotypes
Early cardiac repolarization
Ovarian reserve
Brain development
Thyroid function
"Schizophrenia, bipolar disorder and depression (combined)"
Hematological parameters
Testicular dysgenesis syndrome
Ileal carcinoids
Neuroblastoma
IgE grass sensitization
Allergic rhinitis
Response to TNF antagonist treatment
Adverse response to aromatase inhibitors
Insulin resistance/response
Pubertal anthropometrics
Narcolepsy
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)
Conduct disorder (maternal expressed emotions interaction)
Attention deficit hyperactivity disorder and conduct disorder
Crohn's disease and sarcoidosis (combined)
Life threatening arrhythmia
Black vs. blond hair color
Black vs. red hair color
Cardiovascular disease risk factors
Squamous cell carcinoma
Scoliosis
Colorectal cancer (environment interaction)
DNA methylation (parent-of-origin)
DNA methylation (variation)
Pulmonary arterial hypertension (without BMPR2 mutations)
Coronary artery calcification
β2-Glycoprotein I (β2-GPI) plasma levels
Relative hand skill in reading disability
Relative hand skill
Immune response to anthrax vaccine
Subclinical brain infarct
Ulcerative colitis or Crohn's disease
Electroencephalographic traits in alcoholism
Response to Vitamin E supplementation
Response to dabigatran etexilate treatment
Gamma glutamyl transpeptidase
Response to antipsychotic treatment in schizophrenia (working memory)
Response to antipsychotic treatment in schizophrenia (reasoning)
Asthma treatment response
Airflow obstruction
Depression (quantitative trait)
Pulmonary function in asthmatics
Tumor biomarkers
Clozapine-induced agranulocytosis
Urinary symptoms in response to radiotherapy in prostate cancer
Opioid sensitivity
Renal sinus fat
Metabolite levels (HVA/5-HIAA ratio)
Metabolite levels (HVA-5-HIAA Factor score)
Metabolite levels (HVA)
Metabolite levels (5-HIAA)
Metabolite levels (MHPG)
Metabolite levels (5-HIAA/ MHPG Ratio)
Metabolite levels (HVA/MHPG ratio)
Type 2 diabetes and 6 quantitative traits
Non-small cell lung cancer (survival)
Intelligence (childhood)
Retinal vascular caliber
Suicide risk
Response to ximelagatran treatment (increased serum alanine aminotransferase levels)
Factor VII
Hemostatic factors and hematological phenotypes
Fetal hemoglobin levels
HIV-1 progression
Osteonecrosis of the jaw
Cognitive decline
Select biomarker traits
Blue vs. brown eyes
Non-obstructive azoospermia
Crohn's disease (time to surgery)
Crohn's disease (need for surgery)
Testicular germ cell cancer
F-cell distribution
Corneal structure
Memory (short-term)
Brain structure (hippocampal volume)
Brain structure (temporal lobe volume)
IgG glycosylation
Metabolic syndrome (bivariate traits)
Waist Circumference - Triglycerides (WC-TG)
HDL Cholesterol - Triglycerides (HDLC-TG)
Triglycerides-Blood Pressure (TG-BP)
Diabetes (gestational)
Vaccine-related adverse events
Lapatinib-induced hepatotoxicity in breast cancer
Prostate cancer (SNP x SNP interaction)
Other erythrocyte phenotypes
Lung adenocarcinoma (clinical stage)
Response to tamoxifen in breast cancer
Temperament (bipolar disorder)
Obesity (early onset extreme)
Vascular dementia
Response to platinum-based chemotherapy in small-cell lung cancer
Non-alcoholic fatty liver disease histology (lobular)
Non-alcoholic fatty liver disease histology (AST)
Rhegmatogenous retinal detachment
F-cell distribution in sickle cell anaemia
Neuranatomic and neurocognitive phenotypes
Psychosis (methamphetamine induced)
Alcoholism (heaviness of drinking)
Alcoholism (12-month weekly alcohol consumption)
Alcoholism (alcohol use disorder factor score)
Alcoholism (alcohol dependence factor score)
Vitamin D insufficiency
Stevens-Johnson syndrome
Freckling
Common traits (Other)
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)
Liver enzyme levels
Biomedical quantitative traits
Aging
Quantitative traits
Serum prostate-specific antigen levels
Vascular constriction
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
Lupus
Common variable immunodeficiency
Neuroblastoma (high-risk)
Acute lung injury
Inattentive symptoms
Hyperactive-impulsive symptoms
Optic disc parameters
Aspirin intolerance in asthmatics
Age-related macular degeneration (smoking status interaction)
Age-related macular degeneration (extreme sampling)
Response to antidepressant treatment
Brain structure
Beta thalassemia/hemoglobin E disease
Attention deficit hyperactivity disorder (time to onset)
Cortisol secretion
Brain imaging
Heart rate variability traits
Social and non-social autistic-like traits
Folate pathway vitamin levels
Acenocoumarol maintenance dosage
Cerebrospinal T-tau levels
Cerebrospinal P-tau181p levels
Asthma or atopy (farm exposure interaction)
Hair morphology
N-glycan levels
Autism spectrum disorders (language delay)
Glaucoma (exfoliation)
Coronary spasm
Volumetric brain MRI
Cognitive test performance
Exercise treadmill test traits
Echocardiographic traits
Endothelial function traits
Glioma (high-grade)
Large B-cell lymphoma
Attention deficit hyperactivity disorder motor coordination
Primary tooth development (number of teeth)
Primary tooth development (time to first tooth eruption)
5-HTT brain serotonin transporter levels
Functional MRI
Insulin-like growth factors
Carotenoid and tocopherol levels
Iron deficiency
Cardiac muscle measurement
Optic nerve measurement (cup area)
Optic nerve measurement (rim area)
Optic nerve measurement (disc area)
Optic nerve measurement (cup-to-disc ratio)
Lymphoma
Response to acetaminophen (hepatotoxicity)
Iris color
Tardive dyskinesia in schizophrenia
Myocardial infarction (early onset)
Parkinson's disease (familial)
Environmental confusion in the home
Multiple sclerosis (age of onset)
Normalized brain volume
Brain lesion load
YKL-40 levels
Atrial fibrillation/atrial flutter
Migraine in psychiatric disorder
Carotid atherosclerosis in HIV infection
HIV (mother-to-child transmission)
Celiac disease or Rheumatoid arthritis
Bipolar disorder (age of onset and psychotic symptoms)
Natriuretic peptide levels
Heroin addiction
Beta-trace protein levels
Follicular lymphoma
Cardiovascular risk factors (age interaction)
Cardiovascular risk factors
Electrocardiographic conduction measures
Creutzfeldt-Jakob disease (variant)
Glycemic control in type 1 diabetes (HbA1c)
Ankle-brachial index
Osteosarcoma
Pulmonary function (smoking interaction)
Insulin-related traits
Osteoporosis-related phenotypes
Suicide attempts in bipolar disorder
Serum selenium levels
Information processing speed
Event-related brain oscillations
Erectile dysfunction and prostate cancer treatment
Response to platinum-based chemotherapy in non-small-cell lung cancer
Soluble levels of adhesion molecules
Alcohol consumption (transferrin glycosylation)
Atrioventricular conduction
Head circumference (infant)
Bipolar disorder (Negative mood delusions)
Non-albumin protein levels
HPV seropositivity
Age-related macular degeneration (wet)
Vitamin E levels
Neonatal lupus
Partial epilepsies
Influenza (severity)
Esophageal cancer and gastric cancer
Wilms tumor
Sex ratio at birth
Anthropometric traits in newborns
Stroke (pediatric)
Caffeine consumption
Drinking behavior
Response to platinum-based chemotherapy in small cell and non-small cell lung cancers
Preeclampsia
Sunburns
Non-melanoma skin cancer
Cholelithiasis-related traits in sickle cell anemia
Circulating myeloperoxidase levels (serum)
Circulating myeloperoxidase levels (plasma)
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (alkaline phosphatase)
Liver enzyme levels (gamma-glutamyl transferase)
Formal thought disorder in schizophrenia
Brain connectivity
Body mass index in non-asthmatics
Body mass index in asthmatics
Obsessive-compulsive disorder
Amyotrophic lateral sclerosis (age of onset)
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals
Axial length
Response to fenofibrate (adiponectin levels)
Disc degeneration (lumbar)
Chronic kidney disease and serum creatinine levels
Serum ceruloplasmin levels
LDL (oxidized)
Response to fenofibrate
Periodontal microbiota
Dengue shock syndrome
Erythrocyte sedimentation rate
White blood cell types
QT interval (drug interaction)
Estradiol plasma levels (breast cancer)
Aspirin hydrolysis (plasma)
Venous thromboembolism (SNP x SNP interaction)
HbA2 levels
Response to amphetamines
Psychosis and Alzheimer's disease
Psychosis in Alzheimer's disease
Response to platinum-based agents
Dental caries
Response to gemcitabine in pancreatic cancer
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
Dermatomyositis
Coronary arterial lesions in patients with Kawasaki disease
Sexual dysfunction (SSRI/SNRI-related)
Cardiovascular heart disease in diabetics
Type 2 diabetes (dietary heme iron intake interaction)
Age-related macular degeneration (choroidal neovascularisation)
Age-related macular degeneration (geographic atrophy)
Age-related macular degeneration (CNV vs. GA)
Palmitic acid (16:0) levels
Stearic acid (18:0) levels
Esophageal cancer (squamous cell)
Esophageal cancer (alcohol interaction)
Oral cancers (chewing tobacco related)
Cystic fibrosis (meconium ileus)
Sexual dysfunction (female)
Age at smoking initiation in chronic obstructive pulmonary disease
Lifetime average cigarettes per day in chronic obstructive pulmonary disease
Capecitabine sensitivity
Pulmonary function decline
Hypertension risk in short sleep duration
Body mass index (SNP x SNP interaction)
Bone mineral density (wrist)
Small-cell lung cancer (survival)
Response to bleomycin (chromatid breaks)
Reporting of stressful life event
Alcohol withdrawal symptoms
Epirubicin-induced leukopenia
Adverse response to carbamazepine
Asthma (bronchodilator response)
Response to cholinesterase inhibitors in Alzheimer's disease
Self-employment
Alzheimer's disease (cognitive decline)
Thyroid hormone levels
Retinopathy in non-diabetics
Aspirin exacerbated respiratory disease in asthmatics
Otitis media (chronic/recurrent)
Podoconiosis
Hypertension (SNP x SNP interaction)
Coronary heart disease (SNP X SNP interaction)
Gambling
Peripartum cardiomyopathy
Response to anti-depressant treatment in major depressive disorder
Lean body mass and age at menarche (combined)
Esophageal squamous cell cancer (length of survival)
Odorant perception (isobutyraldehyde)
Odorant perception (β-damascenone)
Odorant perception (β-ionone)
Molar-incisor hypomineralization
Epstein-Barr virus immune response (EBNA-1)
"Thyroid cancer (Papillary, radiation-related)"
Myasthenia gravis
Multiple sclerosis (OCB status)
Periodontitis (DPAL)
Periodontitis (PAL4Q3)
Periodontitis (Mean PAL)
Periodontitis (CDC/AAP)
Anxiety in major depressive disorder
Anxiety and major depressive disorder
Alcohol and nicotine co-dependence
Type 1 diabetes nephropathy
B cell non-Hodgkin lymphoma
Platelet reactivity
Response to tocilizumab in rheumatoid arthritis
Intracranial volume
Lipid levels in hepatitis C treatment
Body mass index and cholesterol (psychopharmacological treatment)
Renal transplant outcome
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
Glutamate decarboxylase autoantibody levels in type 1 diabetes
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes
Gastric parietal cell autoantibody levels in type 1 diabetes
Thyroid peroxidase autoantibody levels in type 1 diabetes
Diabetic peripheral neuropathy in type 2 diabetes
Facial morphology traits (63 three-dimensional facial segments)
Macular thickness
Hyper-LDL-cholesterolemia
Hypo-HDL-cholesterolemia
Dyslipidemia
Childhood body fatness
Sick sinus syndrome
Oxidized LDL cholesterol levels
Asthma (moderate or severe)
Resistance to Mycobacterium tuberculosis infection
Response to cognitive-behavioural therapy in anxiety and major depressive disorders
Response to cognitive-behavioural therapy in anxiety disorder
Fulminant type 1 diabetes
Fragile X syndrome
Kynurenine levels
Arginine levels
Asparagine levels
Sarcosine levels
Citrulline levels
Glutamate levels
Acetylcarnitine levels
Histidine levels
Butyrylcarnitine levels
Methylglutarylcarnitine levels
Methionine levels
Pimelylcarnitine levels
Phenylalanine levels
Nonaylcarnitine levels
Serine levels
Decenoylcarnitine levels
Tryptophan levels
Dodecenoylcarnitine levels
Tetradecenoylcarnitine levels
Symmetric dimethylarginine levels
alpha-Aminoadipic acid levels
Methioninesulfoxide levels
trans-Hydroxyproline levels
Aspartate levels
Spermidine levels
Propionylcarnitine levels
Valerylcarnitine levels
Hexanoylcarnitine levels
Ornithine levels
Octanoylcarnitine levels
Proline levels
Decanoylcarnitine levels
Threonine levels
Dodecanoylcarnitine levels
Tetradecanoylcarnitine levels
Acetylornithine levels
Tetradecadienylcarnitine levels
Hexadecanoylcarnitine levels
Hexadecenoylcarnitine levels
Octadecanoylcarnitine levels
Octadecenoylcarnitine levels
Octadecandienylcarnitine levels
lysoPhosphatidylcholine acyl C14:0 levels
lysoPhosphatidylcholine acyl C16:1 levels
lysoPhosphatidylcholine acyl C17:0 levels
lysoPhosphatidylcholine acyl C18:0 levels
lysoPhosphatidylcholine acyl C18:2 levels
lysoPhosphatidylcholine acyl C20:4 levels
lysoPhosphatidylcholine acyl C26:1 levels
lysoPhosphatidylcholine acyl C16:0 levels
lysoPhosphatidylcholine acyl C18:1 levels
lysoPhosphatidylcholine acyl C20:3 levels
lysoPhosphatidylcholine acyl C24:0 levels
lysoPhosphatidylcholine acyl C26:0 levels
lysoPhosphatidylcholine acyl C28:0 levels
lysoPhosphatidylcholine acyl C28:1 levels
Phosphatidylcholine diacyl C24:0 levels
Phosphatidylcholine diacyl C26:0 levels
Phosphatidylcholine diacyl C30:0 levels
Phosphatidylcholine diacyl C32:0 levels
Phosphatidylcholine diacyl C32:1 levels
Phosphatidylcholine diacyl C32:2 levels
Phosphatidylcholine diacyl C34:1 levels
Phosphatidylcholine diacyl C34:2 levels
Phosphatidylcholine diacyl C34:3 levels
Phosphatidylcholine diacyl C34:4 levels
Phosphatidylcholine diacyl C36:0 levels
Phosphatidylcholine diacyl C36:2 levels
Phosphatidylcholine diacyl C36:3 levels
Phosphatidylcholine diacyl C36:4 levels
Phosphatidylcholine diacyl C36:5 levels
Phosphatidylcholine diacyl C36:6 levels
Phosphatidylcholine diacyl C38:0 levels
Phosphatidylcholine diacyl C38:3 levels
Phosphatidylcholine diacyl C38:4 levels
Phosphatidylcholine diacyl C38:5 levels
Phosphatidylcholine diacyl C38:6 levels
Phosphatidylcholine diacyl C40:2 levels
Phosphatidylcholine diacyl C40:3 levels
Phosphatidylcholine diacyl C40:4 levels
Phosphatidylcholine diacyl C40:5 levels
Phosphatidylcholine diacyl C40:6 levels
Phosphatidylcholine diacyl C42:0 levels
Phosphatidylcholine diacyl C42:1 levels
Phosphatidylcholine diacyl C42:4 levels
Phosphatidylcholine diacyl C42:5 levels
Phosphatidylcholine diacyl C42:6 levels
Phosphatidylcholine acyl-alkyl C30:1 levels
Phosphatidylcholine acyl-alkyl C30:2 levels
Phosphatidylcholine acyl-alkyl C32:1 levels
Phosphatidylcholine acyl-alkyl C32:2 levels
Phosphatidylcholine acyl-alkyl C34:1 levels
Phosphatidylcholine acyl-alkyl C34:2 levels
Phosphatidylcholine acyl-alkyl C34:3 levels
Phosphatidylcholine acyl-alkyl C36:2 levels
Phosphatidylcholine acyl-alkyl C36:3 levels
Phosphatidylcholine acyl-alkyl C36:4 levels
Phosphatidylcholine acyl-alkyl C36:5 levels
Phosphatidylcholine acyl-alkyl C38:0 levels
Phosphatidylcholine acyl-alkyl C38:1 levels
Phosphatidylcholine acyl-alkyl C38:2 levels
Phosphatidylcholine acyl-alkyl C38:3 levels
Phosphatidylcholine acyl-alkyl C38:4 levels
Phosphatidylcholine acyl-alkyl C38:5 levels
Phosphatidylcholine acyl-alkyl C38:6 levels
Phosphatidylcholine acyl-alkyl C40:1 levels
Phosphatidylcholine acyl-alkyl C40:3 levels
Phosphatidylcholine acyl-alkyl C40:4 levels
Phosphatidylcholine acyl-alkyl C40:5 levels
Phosphatidylcholine acyl-alkyl C40:6 levels
Phosphatidylcholine acyl-alkyl C42:1 levels
Phosphatidylcholine acyl-alkyl C42:2 levels
Phosphatidylcholine acyl-alkyl C42:3 levels
Phosphatidylcholine acyl-alkyl C42:4 levels
Phosphatidylcholine acyl-alkyl C42:5 levels
Phosphatidylcholine acyl-alkyl C44:5 levels
Phosphatidylcholine acyl-alkyl C44:6 levels
Sphingomyeline C16:0 levels
Sphingomyeline C16:1 levels
Sphingomyeline C18:0 levels
Sphingomyeline C18:1 levels
Sphingomyeline C20:2 levels
Sphingomyeline C24:0 levels
Sphingomyeline C24:1 levels
Hydroxysphingomyeline C14:1 levels
Hydroxysphingomyeline C16:1 levels
Hydroxysphingomyeline C22:1 levels
Hydroxysphingomyeline C22:2 levels
Low hand grip strength (60 years and older) (EWGSOP)
Low hand grip strength (60 years and older) (FNIH)
Mental health related quality of life
Physical health related quality of life
aparc-Desikan lh volume parahippocampal
aparc-Desikan lh volume paracentral
aparc-Desikan lh volume parsopercularis
aparc-Desikan lh volume parsorbitalis
aparc-Desikan lh volume parstriangularis
aparc-Desikan lh volume pericalcarine
aparc-Desikan lh volume postcentral
aparc-Desikan lh volume posteriorcingulate
aparc-Desikan lh volume precentral
aparc-Desikan lh volume precuneus
aparc-Desikan lh volume rostralanteriorcingulate
aparc-Desikan lh volume rostralmiddlefrontal
aparc-Desikan lh volume superiorfrontal
aparc-Desikan lh volume superiorparietal
aparc-Desikan lh volume superiortemporal
aparc-Desikan lh volume supramarginal
aparc-Desikan lh volume frontalpole
aparc-Desikan lh volume transversetemporal
aparc-Desikan lh volume insula
aparc-Desikan rh volume bankssts
aparc-Desikan rh volume caudalanteriorcingulate
aparc-Desikan rh volume caudalmiddlefrontal
aparc-Desikan rh volume cuneus
aparc-Desikan rh volume entorhinal
aparc-Desikan rh volume fusiform
ThalamNuclei rh volume AV
ThalamNuclei rh volume LP
ThalamNuclei lh volume LD
ThalamNuclei rh volume LD
ThalamNuclei lh volume Whole-thalamus
ThalamNuclei rh volume Whole-thalamus
Brainstem global volume Medulla
Brainstem global volume Pons
Brainstem global volume SCP
Brainstem global volume Midbrain
Brainstem global volume Whole-brainstem
aparc-Desikan lh volume bankssts
aparc-Desikan lh volume caudalanteriorcingulate
aparc-Desikan lh volume caudalmiddlefrontal
aparc-Desikan lh volume cuneus
aparc-Desikan lh volume entorhinal
aparc-Desikan lh volume fusiform
aparc-Desikan lh volume inferiorparietal
aparc-Desikan lh volume inferiortemporal
aparc-Desikan lh volume isthmuscingulate
aparc-Desikan lh volume lateraloccipital
aparc-Desikan lh volume lateralorbitofrontal
aparc-Desikan lh volume lingual
aparc-Desikan lh volume medialorbitofrontal
aparc-Desikan lh volume middletemporal
ThalamNuclei lh volume Pc
HippSubfield rh volume Whole-hippocampal-body
ThalamNuclei lh volume LP
HippSubfield rh volume Whole-hippocampus
ThalamNuclei rh volume MGN
ThalamNuclei rh volume PuI
ThalamNuclei rh volume PuM
ThalamNuclei rh volume L-Sg
ThalamNuclei rh volume VPL
ThalamNuclei rh volume CM
ThalamNuclei rh volume VLa
ThalamNuclei rh volume PuA
ThalamNuclei lh volume PuA
ThalamNuclei rh volume Pf
ThalamNuclei rh volume VAmc
ThalamNuclei rh volume MDl
ThalamNuclei lh volume MDl
ThalamNuclei rh volume MV(Re)
ThalamNuclei rh volume CeM
ThalamNuclei rh volume VM
ThalamNuclei rh volume PuL
ThalamNuclei rh volume CL
ThalamNuclei rh volume VLp
ThalamNuclei rh volume Pc
ThalamNuclei lh volume CL
HippSubfield rh volume HATA
ThalamNuclei lh volume VLp
HippSubfield rh volume Whole-hippocampal-head
ThalamNuclei rh volume LGN
ThalamNuclei lh volume MGN
ThalamNuclei lh volume LGN
ThalamNuclei lh volume PuI
ThalamNuclei lh volume PuM
ThalamNuclei lh volume L-Sg
ThalamNuclei lh volume VPL
ThalamNuclei lh volume CM
ThalamNuclei lh volume VLa
ThalamNuclei rh volume MDm
ThalamNuclei lh volume MDm
ThalamNuclei lh volume Pf
ThalamNuclei lh volume VAmc
ThalamNuclei rh volume VA
ThalamNuclei lh volume CeM
ThalamNuclei lh volume VA
ThalamNuclei lh volume MV(Re)
ThalamNuclei lh volume VM
ThalamNuclei rh volume Pt
ThalamNuclei lh volume PuL
ThalamNuclei lh volume Pt
ThalamNuclei lh volume AV
Carotid plaque
Strabismus
Arterial stiffness index
Cognitive empathy
Sub-foveal choroidal thickness
Health literacy
Age-related macular degeneration (MTAG)
Acute lymphoblastic leukemia (B-cell precursor)
Candidemia
Autoimmune traits (pleiotropy)
Systolic blood pressure (education interaction)
Diastolic blood pressure (education interaction)
aparc-Desikan rh volume transversetemporal
aparc-Desikan rh volume insula
BA-exvivo lh volume BA1
BA-exvivo lh volume BA2
BA-exvivo lh volume BA3a
BA-exvivo lh volume BA3b
BA-exvivo lh volume BA4a
BA-exvivo lh volume BA4p
BA-exvivo lh volume BA6
BA-exvivo lh volume BA44
BA-exvivo lh volume BA45
BA-exvivo lh volume V1
BA-exvivo lh volume V2
BA-exvivo lh volume MT
BA-exvivo lh volume perirhinal
BA-exvivo lh volume entorhinal
BA-exvivo rh volume BA1
BA-exvivo rh volume BA2
BA-exvivo rh volume BA3a
BA-exvivo rh volume BA3b
BA-exvivo rh volume BA4a
BA-exvivo rh volume BA4p
BA-exvivo rh volume BA6
BA-exvivo rh volume BA44
BA-exvivo rh volume BA45
rfMRI connectivity (ICA100 edge 171)
rfMRI connectivity (ICA100 edge 172)
aparc-DKTatlas lh volume lateraloccipital
aparc-DKTatlas lh volume lateralorbitofrontal
aparc-DKTatlas lh volume lingual
aparc-DKTatlas lh volume medialorbitofrontal
aparc-DKTatlas lh volume middletemporal
aparc-DKTatlas lh volume parahippocampal
aparc-DKTatlas lh volume paracentral
aparc-DKTatlas lh volume parsopercularis
aparc-DKTatlas lh volume parsorbitalis
aparc-DKTatlas lh volume parstriangularis
aparc-DKTatlas lh volume pericalcarine
aparc-DKTatlas lh volume postcentral
aparc-DKTatlas lh volume posteriorcingulate
aparc-DKTatlas lh volume precentral
aparc-DKTatlas lh volume precuneus
aparc-DKTatlas lh volume rostralanteriorcingulate
aparc-DKTatlas lh volume rostralmiddlefrontal
aparc-DKTatlas lh volume superiorfrontal
aparc-DKTatlas lh volume superiorparietal
aparc-DKTatlas lh volume superiortemporal
aparc-DKTatlas lh volume supramarginal
aparc-DKTatlas lh volume transversetemporal
aparc-DKTatlas lh volume insula
aparc-DKTatlas rh volume superiorfrontal
aparc-DKTatlas rh volume superiorparietal
aparc-DKTatlas rh volume superiortemporal
aparc-DKTatlas rh volume supramarginal
aparc-DKTatlas rh volume transversetemporal
aparc-DKTatlas rh volume insula
aparc-a2009s lh volume G+S-frontomargin
aparc-a2009s lh volume G+S-occipital-inf
aparc-a2009s lh volume G+S-paracentral
aparc-a2009s lh volume G+S-subcentral
aparc-a2009s lh volume G+S-transv-frontopol
aparc-a2009s lh volume G+S-cingul-Ant
aparc-a2009s lh volume G+S-cingul-Mid-Ant
aparc-a2009s lh volume G+S-cingul-Mid-Post
aparc-a2009s lh volume G-cingul-Post-dorsal
aparc-a2009s lh volume G-cingul-Post-ventral
aparc-a2009s lh volume G-cuneus
aparc-a2009s lh volume G-front-inf-Opercular
aparc-a2009s lh volume G-front-inf-Orbital
aparc-a2009s lh volume G-front-inf-Triangul
aparc-a2009s lh volume G-front-middle
aparc-a2009s lh volume G-front-sup
aparc-a2009s lh volume G-Ins-lg+S-cent-ins
aparc-a2009s lh volume G-insular-short
aparc-a2009s lh volume G-occipital-middle
BA-exvivo rh volume V1
BA-exvivo rh volume V2
BA-exvivo rh volume MT
BA-exvivo rh volume perirhinal
BA-exvivo rh volume entorhinal
aparc-DKTatlas lh volume caudalanteriorcingulate
aparc-DKTatlas lh volume caudalmiddlefrontal
aparc-DKTatlas lh volume cuneus
aparc-DKTatlas lh volume entorhinal
aparc-DKTatlas lh volume fusiform
aparc-DKTatlas lh volume inferiorparietal
aparc-DKTatlas lh volume inferiortemporal
aparc-DKTatlas lh volume isthmuscingulate
rfMRI connectivity (ICA100 edge 134)
rfMRI connectivity (ICA100 edge 135)
rfMRI connectivity (ICA100 edge 136)
rfMRI connectivity (ICA100 edge 137)
rfMRI connectivity (ICA100 edge 138)
rfMRI connectivity (ICA100 edge 139)
rfMRI connectivity (ICA100 edge 140)
rfMRI connectivity (ICA100 edge 141)
rfMRI connectivity (ICA100 edge 142)
rfMRI connectivity (ICA100 edge 143)
rfMRI connectivity (ICA100 edge 144)
rfMRI connectivity (ICA100 edge 145)
aparc-DKTatlas rh volume caudalanteriorcingulate
aparc-DKTatlas rh volume caudalmiddlefrontal
aparc-DKTatlas rh volume cuneus
aparc-DKTatlas rh volume entorhinal
aparc-DKTatlas rh volume fusiform
aparc-DKTatlas rh volume inferiorparietal
aparc-DKTatlas rh volume inferiortemporal
aparc-DKTatlas rh volume isthmuscingulate
aparc-DKTatlas rh volume lateraloccipital
aparc-DKTatlas rh volume lateralorbitofrontal
aparc-DKTatlas rh volume lingual
aparc-DKTatlas rh volume medialorbitofrontal
aparc-DKTatlas rh volume middletemporal
aparc-DKTatlas rh volume parahippocampal
aparc-DKTatlas rh volume paracentral
aparc-DKTatlas rh volume parsopercularis
aparc-DKTatlas rh volume parsorbitalis
aparc-DKTatlas rh volume parstriangularis
aparc-DKTatlas rh volume pericalcarine
aparc-DKTatlas rh volume postcentral
aparc-DKTatlas rh volume posteriorcingulate
aparc-DKTatlas rh volume precentral
aparc-DKTatlas rh volume precuneus
aparc-DKTatlas rh volume rostralanteriorcingulate
aparc-DKTatlas rh volume rostralmiddlefrontal
Immune thrombocytopenia
Left-handedness
Extranodal natural killer T-cell lymphoma (nasal type)
Central serous retinopathy
Poor prognosis in Crohn's disease
Heart rate in heart failure with reduced ejection fraction
Group IIA secretory phospholipase A2 levels in individuals with elevated hsCRP
Sib-shared facial trait 3; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 4; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 5; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 6; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 7; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 8; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 9; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 10; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 11; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 12; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 13; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 14; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 15; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 16; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 17; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 18; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 19; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 20; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 21; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 22; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 23; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 24; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 25; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 26; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 27; Facial segment 1; 3D morphology of the full face
"Sib-shared facial trait 153; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 154; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 155; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 156; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 157; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 158; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 159; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 160; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 225; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 226; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 227; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 228; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 229; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 230; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 231; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 232; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 233; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 234; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 235; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 236; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 237; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 238; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 103; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 129; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 105; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 131; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 107; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 133; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 109; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 135; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 111; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 137; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 113; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 139; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 115; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 141; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 117; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 143; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 119; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 145; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 121; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 147; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 123; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 149; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 150; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 126; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 152; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 128; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 104; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 130; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 106; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 132; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 108; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 134; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 110; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 136; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 112; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 138; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 114; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 140; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 116; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 142; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 118; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 144; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 120; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 146; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 122; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 148; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 124; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 125; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 151; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 127; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 180; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 181; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 182; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 183; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 184; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 185; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 186; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 187; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 188; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 189; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 190; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 191; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 192; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 193; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 194; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 195; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 196; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 197; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 198; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 199; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 200; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 201; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 202; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 203; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 204; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 434; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 435; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 436; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 437; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 438; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 439; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 440; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 441; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 442; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 443; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 444; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 445; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 446; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 447; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 448; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 449; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 450; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 451; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 452; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 453; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 454; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 455; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 456; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 457; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 458; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 97; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 98; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 99; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 100; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 101; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 102; Facial segment 2; 3D morphology of the nose
"Sib-shared facial trait 161; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 162; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 163; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 164; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 165; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 166; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 167; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 168; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 169; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 170; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 171; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 172; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 173; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 174; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 175; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 176; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 177; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 178; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
"Sib-shared facial trait 179; Facial segment 3; 3D morphology of the upper and lower face, excluding the nose"
Sib-shared facial trait 409; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 410; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 411; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 412; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 413; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 414; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 415; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 416; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 417; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 418; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 419; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 420; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 421; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 422; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 423; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 424; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 425; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 426; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 427; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 428; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 429; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 430; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 431; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 432; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 433; Facial segment 13; 3D morphology of the chin and jaw
Sib-shared facial trait 205; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 206; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 207; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 208; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 209; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 210; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 211; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 212; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 213; Facial segment 4; 3D morphology of the upper lip
Sib-shared facial trait 214; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 215; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 216; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 217; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 218; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 219; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 220; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 221; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 222; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 223; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 224; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 404; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 405; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 406; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 407; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 408; Facial segment 12; 3D morphology of the cheeks
Sib-shared facial trait 53; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 54; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 55; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 240; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 241; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 242; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 243; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 244; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 245; Facial segment 6; 3D morphology of the lower face
Sib-shared facial trait 56; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 57; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 58; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 59; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 60; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 61; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 62; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 63; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 64; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 65; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 66; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 67; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 68; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 69; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 70; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 71; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 72; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 73; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 74; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 75; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 76; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 77; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 78; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 79; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 80; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 81; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 82; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 83; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 84; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 85; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 86; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 87; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 88; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 89; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 90; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 91; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 92; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 93; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 94; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 95; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 96; Facial segment 2; 3D morphology of the nose
Sib-shared facial trait 28; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 29; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 30; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 31; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 32; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 33; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 34; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 35; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 36; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 37; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 38; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 39; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 40; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 41; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 42; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 43; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 44; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 45; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 46; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 47; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 48; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 49; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 50; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 51; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 52; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 239; Facial segment 5; 3D morphology of the nose
Sib-shared facial trait 1; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 2; Facial segment 1; 3D morphology of the full face
Sib-shared facial trait 484; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 485; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 486; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 487; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 488; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 489; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 490; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 491; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 492; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 493; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 494; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 495; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 496; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 497; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 498; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 499; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 500; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 501; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 502; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 503; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 504; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 505; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 506; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 507; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 508; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 609; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 610; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 611; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 612; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 613; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 614; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 615; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 616; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 617; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 618; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 619; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 620; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 621; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 622; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 623; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 624; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 625; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 626; Facial segment 26; 3D morphology of the chin and outer jaw
Sib-shared facial trait 627; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 628; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 629; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 630; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 631; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 632; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 633; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 634; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 635; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 636; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 637; Facial segment 27; 3D morphology of the chin and inner jaw
Sib-shared facial trait 638; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 639; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 640; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 641; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 642; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 643; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 644; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 645; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 646; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 647; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 648; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 649; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 650; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 651; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 652; Facial segment 28; 3D morphology of the middle forehead
Sib-shared facial trait 653; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 654; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 655; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 656; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 657; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 658; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 509; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 510; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 511; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 512; Facial segment 16; 3D morphology of the upper lip
Sib-shared facial trait 513; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 514; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 515; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 516; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 517; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 518; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 519; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 520; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 521; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 522; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 523; Facial segment 17; 3D morphology of the upper lip
Sib-shared facial trait 524; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 525; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 526; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 527; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 528; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 529; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 530; Facial segment 18; 3D morphology of the philtrium
Sib-shared facial trait 531; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 532; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 533; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 459; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 460; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 461; Facial segment 14; 3D morphology of the forehead
Sib-shared facial trait 462; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 463; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 464; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 465; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 466; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 467; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 468; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 469; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 470; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 471; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 472; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 473; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 474; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 475; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 476; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 477; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 478; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 479; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 480; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 481; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 482; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 483; Facial segment 15; 3D morphology of the eyes and temples
Sib-shared facial trait 659; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 660; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 661; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 662; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 663; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 664; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 665; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 666; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 667; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 668; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 669; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 670; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 671; Facial segment 29; 3D morphology of the temple lines
Sib-shared facial trait 672; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 673; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 674; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 675; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 676; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 677; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 678; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 679; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 680; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 681; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 682; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 683; Facial segment 30; 3D morphology of the eyes
Sib-shared facial trait 534; Facial segment 19; 3D morphology of the upper vermillion
Sib-shared facial trait 535; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 536; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 537; Facial segment 20; 3D morphology of the nose sides
Sib-shared facial trait 538; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 539; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 540; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 541; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 542; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 543; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 544; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 545; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 546; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 547; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 548; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 549; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 550; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 551; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 552; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 553; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 554; Facial segment 21; 3D morphology of the nose sides
Sib-shared facial trait 555; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 556; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 557; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 558; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 559; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 560; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 561; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 562; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 563; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 564; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 565; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 566; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 567; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 568; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 569; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 570; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 571; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 572; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 573; Facial segment 22; 3D morphology of the nose apex
Sib-shared facial trait 574; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 575; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 576; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 577; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 578; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 579; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 580; Facial segment 23; 3D morphology of the nose bridge
Sib-shared facial trait 581; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 582; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 583; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 584; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 585; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 586; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 587; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 588; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 589; Facial segment 24; 3D morphology of the cheeks
Sib-shared facial trait 590; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 591; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 592; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 593; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 594; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 595; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 596; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 597; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 598; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 599; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 600; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 601; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 602; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 603; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 604; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 605; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 606; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 607; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 608; Facial segment 25; 3D morphology of the cheeks
Sib-shared facial trait 709; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 710; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 711; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 712; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 713; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 714; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 715; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 716; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 717; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 718; Facial segment 31; 3D morphology of the cheekbones and temples
Sib-shared facial trait 719; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 720; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 721; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 722; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 723; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 724; Facial segment 32; 3D morphology of the upper lip
Sib-shared facial trait 725; Facial segment 33; 3D morphology of the upper lip
Sib-shared facial trait 726; Facial segment 33; 3D morphology of the upper lip
Sib-shared facial trait 727; Facial segment 33; 3D morphology of the upper lip
Sib-shared facial trait 728; Facial segment 33; 3D morphology of the upper lip
